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ABSTRACT 
 
Despite its importance and wide use as oxidizing agent, aqueous H2O2 has 
disadvantages. It easily decomposes, and when the substrates are not water-soluble, 
biphasic reaction mixtures are required. Thus, oxidizing agents that are anhydrous and 
soluble in organic solvents are desired. To this purpose, several H2O2 adducts of 
phosphine oxides, for example [
t
Bu3PO•H2O2]2 and [Ph3PO•H2O2]2•H2O2, have been 
synthesized and characterized. These adducts represent an extension to the adducts 
previously reported by the Bluemel group, and display comparable physical properties.  
Furthermore, di(hydroperoxy)alkane adducts, R3PO•(HOO)2CR'R" (R, R', R" = 
alkyl, aryl), were synthesized and fully characterized. These adducts can be constructed 
using a wide variety of alkanes and phosphine oxides. All di(hydroperoxy)alkane 
adducts are structurally well defined as proven by single crystal X-ray analysis, and they 
contain two active oxygen atoms per assembly.  
These adducts of the type R3PO•(HOO)2CR'R" are highly soluble in organic 
solvents, allowing for oxidation reactions to occur in one phase. Moreover, there are 
many beneficial features to be harvested from their well-defined molecular structure and 
relatively anhydrous character. For example, selective and fast oxidation of 
dialkylsulfides to corresponding sulfoxides can be accomplished, without overoxidation 
to sulfones, because the solid oxidizing agents can easily be administered 
stoichiometrically. The adducts can also successfully oxidize substrates sensitive to 
hydrolysis, such as Ph2P-PPh2, without cleaving the P-P bond.  
 iii 
 
The R3PO•(HOO)2CR'R" adducts are robust and practically no decomposition is 
found after storing the solids for 100 days at 4 °C. At room temperature, the adducts 
slowly decompose over time, via the release of oxygen gas. When exposed to higher 
temperatures or mechanical stress such as hammering or grinding, no sudden release of 
energy and/or oxygen was observed, attesting to the stability of the adducts. In the 
presence of catalytic amounts of acid, adducts with di(hydroperoxy)cycloalkane moieties 
decompose by undergoing a Baeyer-Villiger oxidation, and the 
di(hydroperoxy)cycloalkanes are transformed into the corresponding lactones.  
The R3PO•(HOO)2CR'R" adducts are stable, solid, stoichiometric and soluble 
materials, and can serve as an excellent complement to aqueous H2O2 as oxidizing 
agents.  
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NOMENCLATURE 
 
δ chemical shift in ppm 
λ wavelength 
13
C carbon nucleus (NMR) 
2
H deuterium nucleus (NMR) 
1
H proton nucleus (NMR) 
31
P phosphorus nucleus (NMR) 
{
1
H} proton decoupled (NMR) 
Å  Å ngstrom 
br broad 
Bu butyl 
COSY Correlation SpectroscopY (2D NMR) 
CP cross-polarization 
CP/MAS cross-polarization/magic angle spinning 
CSA chemical shift anisotropy 
Cy cyclohexyl 
d doublet (NMR), days 
D deuterium (
2
H) atom 
DCM dichloromethane 
dppm bis(diphenylphosphino)methane 
dppe bis(diphenylphosphino)ethane 
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dppp bis(diphenylphosphino)propane  
D2O deuterium oxide 
eq equivalents, equatorial (NMR) 
FID free induction decay (NMR) 
FT Fourier Transformation 
h hours 
HSQC heteronuclear single quantum coherence spectroscopy (2D NMR) 
Hz Hertz 
i ipso 
J scalar coupling constant (NMR) 
IR infrared 
m multiplet (NMR) 
m meta 
MAS magic angle spinning 
Me methyl 
NMR nuclear magnetic resonance 
o ortho 
p para 
Ph phenyl 
ppm parts per million 
R alkyl, aryl group 
RT room temperature 
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s singlet (NMR) 
sept septet (NMR) 
t triplet (NMR) 
t tertiary 
T temperature, time 
tert tertiary 
THF tetrahydrofuran 
Δν1/2 signal width at half height 
xs excess 
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CHAPTER I  
INTRODUCTION  
 
 H2O2 is an immensely important reagent for oxidation reactions in organic 
syntheses.
1
 For example, Baeyer-Villiger oxidations
2,3
 and sulfide oxidation processes,
4
 
as well as epoxidation reactions,
5
 are mainly performed using H2O2. Most importantly, 
since the rise of the new propylene oxide processes that use aqueous H2O2 as the oxidant, 
it has turned into a commodity with world capacities well above 2 million tons per 
year.
1a
 The reactions with H2O2 are very selective and efficient, with fast and 
quantitative reactions taking place at low temperatures. Additionally, many oxidation 
reactions with H2O2, for example, the transformation of phosphines to their oxides,
6
 do 
not need any catalyst.  
 Aqueous H2O2 is an enticing oxidizing agent in industrial settings because it is 
cheap, available on a large scale and it can be applied in concentrations up to 85 wt%. Its 
major drawback, however, remains the water byproduct. Aqueous H2O2 solutions used 
in modern industrial processes are very pure and stable, with typical decomposition rates 
of 1% per year. On the other hand, in academic settings 30 wt% aqueous solutions are 
usually purchased as a compromise between potency and safety regulations. In practice, 
with many users, aqueous H2O2 decomposes at unpredictable rates, and the solutions 
have to be titrated
7
 prior to each application when exact stoichiometry is needed. 
Furthermore, in case the reagents are not soluble in water, the oxidation has to be 
 2 
 
performed in a biphasic system, which entails a slow reaction at the phase boundary and 
a phase separation requirement in the workup.   
 Different formulations of H2O2 are also in use, for example, urea hydrogen 
peroxide (UHP) adducts.
8
 However, the UHP adducts are not stoichiometric in nature, 
and urea and water have to be removed after the reaction. Alternatively, alkali metal 
peroxocarbonates have been applied,
9,10
 but like UHP, they are caustic. Unfortunately, 
H2O2 is much less stable under basic conditions. Additionally, many oxidations 
performed with H2O2 are co-catalyzed by acids.
1a
 Besides these materials, encapsulated
11
 
and immobilized versions of hydrogen peroxide are known.
12,13
 Again, the stoichiometry 
of these materials is not very well defined. Furthermore, H2O2 adducts of metal 
complexes have been characterized.
14
 Organic and silicon-containing peroxides are 
important, but can be difficult to synthesize and remove from reaction mixtures.
15
 
 The ideal oxidizing agent is an easy to synthesize, solid and molecular H2O2 
adduct of reproducible stoichiometry that is soluble in organic solvents. This thesis 
describes the discovery of two different peroxide containing adducts of phosphine oxides 
as oxidizing agents − the H2O2 and the di(hydroperoxy)alkane adducts of phosphine 
oxides. In contrast to urea hydrogen peroxide or peroxocarbonates, phosphine oxides are 
only moderate Lewis bases, and they could also function as ligands for Mo or W centers 
in oxidation reactions,
16
 therewith playing a dual role.  
For both types of adducts, once all active peroxide is consumed during an 
oxidation reaction, the remaining phosphine oxide can easily be removed from the 
reaction mixture via reversible adsorption on solid oxide materials, such as silica or 
 3 
 
molecular sieves.
6
 Once the phosphine oxides are retrieved from the support by washing 
with polar solvents,
17
 they can undergo the synthetic procedure to regenerate the adduct.  
In the following chapters, the synthetic methods of each type of adduct are 
described in detail and full characterization data are provided. Furthermore, the potential 
of each type of adduct as stoichiometric oxidizing agent for different oxidation reactions 
is explored.   
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CHAPTER II  
HYDROGEN PEROXIDE ADDUCTS OF PHOSPHINE OXIDES

 
 
Introduction 
 H2O2 adducts of phosphine oxides, such as [Cy3PO•H2O2]2,
6
 have been described 
by the Bluemel group as stoichiometric, well-defined molecules with high melting points 
that are stable over months on the shelf and can easily be crystallized.
6,18
 Previously, a 
single crystal X-ray structure of [Cy3PO•H2O2]2 had been obtained, where the two H2O2 
molecules bridge the two phosphine oxides to form a chair-like structure (Figure 2.1).
6
 
This well-defined molecular structure of [Cy3PO•H2O2]2 allows for exact stoichiometric 
determination of peroxy groups and active oxygen atoms.  
 
 
Figure 2.1. Single crystal X-ray structure of [Cy3PO•H2O2]2.
6
 
                                                 

 Reproduced with permission from “Hydrogen Peroxide and Di(hydroperoxy)propane Adducts of 
Phosphine Oxides as Stoichiometric and Soluble Oxidizing Agents” Ahn, S. H.; Cluff, K. J.; 
Bhuvanesh, N.; Blümel, J. Angew. Chem. 2015, 127, 13539-13543. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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On the other hand, the structural data of (Ph3PO)2•H2O2 have been known for 
decades,
19
 where two phosphine oxide molecules are bridged by a single H2O2 molecule 
(Figure 2.2). Although H2O2 adducts of other phosphine oxide molecules have been 
reported,
6
 single crystal X-ray data have only been obtained for [Cy3PO•H2O2]2
6
 and 
(Ph3PO)2•H2O2
19
 when the work on this thesis was started. Therefore, it was difficult to 
determine the ratio R3PO : H2O2 for a H2O2 adduct of any given phosphine oxide. 
Moreover, adducts of phosphine oxides with less steric bulk are often viscous oils.  
 
 
Figure 2.2. Single crystal X-ray structure of (Ph3PO)2•H2O2.
19
 
 
 
The synthetic method described previously
6
 was applied to various different 
phosphine oxides in an attempt to crystallize another adduct and determine whether the 
chair-like structure found in [Cy3PO•H2O2]2
6
 is unique to Cy3PO, or if this is a general 
motif for trialkylphosphine oxides.  
Previously, 
31
P NMR and IR spectroscopy have been used to confirm the 
presence of H2O2 and the absence of H2O in adduct molecules.
6
 In the 
31
P NMR 
 6 
 
spectrum, the phosphorus peak of an adduct (R3PO)x•(H2O2)y is downfield shifted 
compared to the neat R3PO, as electron density is removed to form the P=O group by 
hydrogen bonding, and phosphorus is deshielded. In the IR spectrum, the O-H band for 
H2O2 appears as a broad band around 3200 cm
-1
, distinct from the O-H band of H2O at 
3400 cm
-1 
(Figure B.1).  
For the newly synthesized H2O2 adducts, both 
31
P NMR and IR spectroscopy 
were performed, and the solubilities of these adducts in common organic solvents were 
measured. 
 
Results and Discussions 
In order to probe whether [R3PO•H2O2]2 represents a general composition of 
hydrogen peroxide adducts of phosphine oxides, analogous compounds with different 
substituents (R = 
t
Bu, Ph) have been synthesized following the previously described 
method.
6
 Indeed, the adduct [
t
Bu3PO•H2O2]2 (1) crystallized as a dimer with two H2O2 
molecules hydrogen-bonded between two phosphine oxide groups in a chair 
conformation (Figure 2.3).
18,20
 The tendency of P=O groups to eagerly form hydrogen 
bonds to H2O2 molecules,
6
 H2O
17
 and silanols
17
 has been described. Recently, hydrogen 
bonding between P=O and phenol -OH groups has also been used to create dimeric 
motifs.
21
 
Many triarylphosphine oxides do not follow this structural trend, and they can 
even lead to different adduct structures and stoichiometries for one given 
 7 
 
triarylphosphine oxide. For example, an adduct of Ph3PO has been described earlier and 
its composition has been determined as (Ph3PO)2•H2O2 with H2O2 bridging two Ph3PO 
molecules.
19
 Two separate attempts to reproduce this result led to (Ph3PO)2•H2O2 (Figure 
2.2)
19
 and a new adduct [Ph3PO•H2O2]2•H2O2 (2) (Figure 2.3).
18,22
 Most probably, due to 
the rigid nature and sterics of the phenyl groups, additional H2O2 molecules can be 
accommodated in the space between the dimers, depending on the reaction conditions. 
 
 
 
Figure 2.3. Single crystal X-ray structures of 1 (left)
18,20
 and 2 (right).
18,22
 
  
 
 The crystalline adduct [Cy3PO•H2O2]2 (3) was easily reproduced in high yield 
following the previously reported synthetic method.
6
 The absence of bulk water 
molecules was confirmed via NMR and IR spectroscopy.  
When solubilized, the hydrogen bond between H2O2 and R3PO reversibly forms, 
and proton exchange can occur between H2O2 and protic solvents. This exchange was 
observed when adduct 3 was dissolved in a CDCl3/D2O (6:1) mixture and stirred 
overnight. The resulting product was precipitated, and analyzed with 
2
H NMR and IR 
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spectroscopy. In the 
2
H NMR spectrum, a broad peak is observed at 10.51 ppm, 
corresponding to the peroxide-bound deuterium (Figure 2.4).  
 
 
 
Figure 2.4. 
1
H NMR spectrum of 3 (top) and 
2
H NMR spectrum of partially deuterated 3 
(bottom). 
 
 
In the 
1
H NMR spectrum of a non-deuterated sample, the -OOH proton peak 
occurs in the same region, at 10.14 ppm. The IR spectrum shows signs of residual H2O2 
(3165.2 cm
-1
) as well as the exchanged D2O2 (2358.9 cm
-1
) (Figure B. 4). 
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One of the most important advantages of the hydrogen peroxide adducts of 
phosphine oxides with respect to their application as oxidizing agents is that they are 
very soluble in organic solvents, rendering biphasic reaction mixtures obsolete. The 
solubilities of 2 and 3 in representative organic solvents have been quantified (Figure 
2.5).
18
 They are substantially higher in polar solvents, with adduct 3 displaying 
remarkably high solubility especially in chlorinated solvents.   
 
 
Figure 2.5. Solubilities of 2 and 3 in representative solvents. 
 
Conclusion 
 In this chapter it has been demonstrated that the H2O2 adducts of 
trialkylphosphine oxides crystallize readily and reproducibly in a dimer structure with a 
 10 
 
chair-type arrangement of the H2O2 moieties. Triarylphosphine oxides can lead to 
different H2O2 contents, and therefore quantification of the ratio R3PO : H2O2 is 
necessary for each new batch. The described adducts do not contain an excess of water 
molecules and are very soluble in representative organic solvents, allowing oxidation 
reactions in a single organic phase. 
 
Experimental 
[
t
Bu3PO•H2O2]2 (1) 
t
Bu3P (20 mg, 0.099 mmol) is weighed into a Schlenk flask inside a glove box. 
The flask is then sealed, brought outside, and acetone (40 mL) is added under a nitrogen 
stream. Once the phosphine is dissolved, aqueous H2O2 (1.0 mL, 10 mmol) is added and 
the reaction mixture is stirred for 1 h. 100 mL of EtOH is then added to the flask, and the 
azeotropic mixture of EtOH and H2O is removed in vacuo at ambient temperature. The 
resulting viscous material is washed with toluene and left to crystallize. The adduct 
[
t
Bu3PO•H2O2]2 is obtained in the form of white rhombic crystals (19 mg, 0.075 mmol, 
76% yield).  
 
NMR (δ, CDCl3), 
31
P{
1
H} 43.16 (s); 
1
H 9.10 (br. s, H2O2), 1.41 (d, 
3
J(
31
P-
1
H) = 12.5 Hz,  
-CH3); 
13
C{
1
H} 39.17 (d, 
1
J(
31
P-
13
C) = 49.6 Hz, PC), 29.00 (s, -CH3). 
NMR (δ, (CD3)2CO), 
31
P{
1
H} 65.61 (s); 
1
H 1.34 (d, 
3
J(
31
P-
1
H) = 12.0 Hz, -CH3); 
13
C{
1
H} 
40.35 (d, 
1
J(
31
P-
13
C) = 51.1 Hz, PC), 30.08 (s, -CH3). mp 122-125 °C. 
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[Ph3PO•H2O2]2•H2O2 (2) 
Ph3P (150 mg, 0.572 mmol) is weighed into a Schlenk flask flushed with 
nitrogen gas. CH2Cl2 (150 mL) is added under a nitrogen stream. Once the phosphine is 
dissolved, aqueous H2O2 (1.0 mL, 10 mmol) is added and the reaction mixture is stirred 
for 30 min. The organic layer is collected via separation funnel, and the solvent is 
removed in vacuo. The resulting white precipitate is dissolved in acetone (60 mL), and 
after the addition of H2O2 (0.1 mL, 1 mmol), the sample is allowed to crystallize. 
[Ph3PO•H2O2]2•H2O2 is obtained in the form of colorless needles (286 mg, 0.434 mmol, 
76% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 32.84 (s); 
1
H 11.24 (br. s, H2O2), 8.93 (br. s, H2O2), 7.67-7.62 
(m, 6H, Ho), 7.58-7.55 (m, 3H, Hp), 7.49-7.45 (m, 6H, Hm); 
13
C{
1
H} 132.43 (s, Cp), 
132.04 (d, 
2
J(
31
P-
13
C) = 10.2 Hz, Co), 130.71 (d, 
1
J(
31
P-
13
C) = 108.8 Hz, Ci), 128.69 (d, 
3
J(
31
P-
13
C) = 12.1 Hz, Cm). mp 143-155 °C. 
 
Deuteration of [Cy3PO•H2O2]2 (3) 
0.5 mL of D2O was added to a solution of 50 mg (0.08 mmol) of [Cy3PO•H2O2]2, 
dissolved in 3 mL of CDCl3, and the mixture was stirred vigorously for 24 h. The 
remaining CDCl3 and D2O were removed via slow evaporation, and the deuterated 
adduct was obtained as white crystalline powder. A sample was prepared for 
2
H NMR 
by dissolving the product in C6H6. 
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CHAPTER III 
SYNTHESIS OF DI(HYDROPEROXY)ALKANE ADDUCTS OF PHOSPHINE 
OXIDES

 
 
Introduction 
 In an attempt to control the R3PO : H2O2 ratio in H2O2 adducts of triaryl-
phosphine oxides, and to be able to work in one organic phase, the solvent for the 
reaction was changed from CH2Cl2 to acetone. Contrary to anticipation, a new class of 
adducts was discovered, with the molecular formula R3PO•(HOO)2CR'R" (R, R', R" = 
alkyl, aryl). For these di(hydroperoxy)alkane adducts the number of active peroxide 
groups is even higher than for H2O2 adducts, as two peroxo groups are bound to one 
phosphine oxide group. The high tendency of these adducts to crystallize makes them an 
ideal source for stoichiometric active peroxides.  
 While di(hydroperoxy)alkanes have been known for a long time,
23
 the only 
preceding report of this class of phosphine oxide adduct was made when H2O2 and 
bis(diphenylphosphino)ethane (dppe) were reacted in acetone in the presence of R2SnCl2 
(R = Me or 
n
Bu) as catalyst to form (Ph2P(O)CH2CH2P(O)Ph2)•((HOO)2CMe2)2.
24
 The 
authors proposed that this adduct could only form with a chelating phosphine that has 
two methylene carbons in the chain between the two P atoms.  
                                                 

 Reproduced with permission from “Hydrogen Peroxide and Di(hydroperoxy)propane Adducts of 
Phosphine Oxides as Stoichiometric and Soluble Oxidizing Agents” Ahn, S. H.; Cluff, K. J.; 
Bhuvanesh, N.; Blümel, J. Angew. Chem. 2015, 127, 13539-13543. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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Here, it will be demonstrated that di(hydroperoxy)alkane adducts of phosphine 
oxides are actually easy to synthesize with a large variety of alkane moieties. Moreover, 
the active oxygen content and the structural mode remain the same for different 
phosphine oxides. A description of the general synthetic method and its mechanism are 
provided in this chapter. 
 
Results and Discussion 
Di(hydroperoxy)alkane adducts of various phosphine oxides and alkanes (4-15) 
were successfully synthesized and obtained in nearly quantitative yields as giant crystals 
(Scheme 3.1). Adducts of the bulky Cy3PO crystallize especially readily, and thus 
Cy3PO was used most often in adduct syntheses. In order to improve the atom economy 
of active oxygen, and to probe the general structure of the di(hydroperoxy)alkane 
adducts, 1,2-bis(diphenylphosphino)ethane (dppe) and 1,2-bis(diphenylphosphino)-
methane (dppm) were treated with acetone and aqueous H2O2. While dppm dioxide only 
formed the adduct with one molecule of (HOO)2CMe2, dppe dioxide formed hydrogen 
bonds with (HOO)2CMe2 at both P=O groups. Encouraged by this success, the dppe 
dioxide adduct synthesis was repeated with 3-pentanone to produce 
(Ph2P(O)CH2CH2P(O)Ph2)•((HOO)2CEt2)2 (15). The discrepancy in the ratio of dppm 
dioxide and (HOO)2CMe2 is studied in detail in the following chapter.  
It is important to note that the di(hydroperoxy)alkane adducts can be generated at 
room temperature and without addition of a strong acid or catalyst.
18,23a,25
 This prevents 
the formation of potentially dangerous cyclic peroxide trimers.
26
 In fact, none of the 
 14 
 
adducts 4-15 displayed any violent release of energy when being ground, hammered, 
stored over months, or heated up. 
 
 
Scheme 3.1. (HOO)2CR'R" adducts of the phosphine oxides 4-12 and the diphosphine 
dioxides 13-15. 
 
  
 
The adducts can be synthesized in a variety of ways (Scheme 3.2). One option is 
to start from the phosphine oxides or their corresponding H2O or H2O2 adducts. 
 15 
 
Alternatively, the phosphines can be used as educts. When starting from the phosphine 
oxides, exclusion of air is not necessary during the adduct synthesis. However, starting 
from the phosphines entails the risk of formation of other unwanted products from 
oxygen insertion into the P-C bonds, and thus the synthesis must be performed in inert 
atmosphere.
6
  
For all starting materials, the adduct formation can be achieved by adding the 
corresponding ketone and H2O2, or the pre-formed di(hydroperoxy)alkane moiety,
23a
 if 
available in stable form. The ketone can serve a dual role as the reaction solvent, or 
CH2Cl2 can be used instead, as the phosphines and phosphine oxides are highly soluble 
in polar chlorinated solvents.  
 
 
 
Scheme 3.2. General synthesis routes for the adducts R3PO•(HOO)2CR'R" (R, R', R" = 
alkyl, aryl). 
  
 
 The mechanism for the formation of the adducts is suggested in Scheme 3.3.
18
 
Two hydroperoxides perform a nucleophilic attack on the carbonyl carbon atom to form 
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the di(hydroperoxy)alkane, which then attaches to the phosphine oxide via hydrogen 
bonds.  
 
 
Scheme 3.3. Suggested mechanism for the formation of adducts R3PO•(HOO)2CR'R" (R, 
R', R" = alkyl, aryl). 
 
 
In order to remove excess water from the solution without decomposing the 
peroxide groups, ethanol is used to form an azeotropic mixture with water. This mixture 
is then removed in a mild vacuum at room temperature, and the adduct is crystallized 
from the remaining solution. Starting from larger ketones, the ensuing (HOO)2CR'R" 
molecule can be safely isolated and dried,
23a
 and combined with pure phosphine oxide at 
a later time to form the adduct. Thus, an azeotropic mixture is unnecessary. Excess 
solvent is removed in vacuo at room temperature, as the peroxide functionality can 
decompose at higher temperatures. The adduct is obtained in the form of crystals from 
the concentrated solution.  
The general synthetic routes outlined in Scheme 3.2 allow for easy recycling of 
the adducts. Once the peroxide oxygen atoms are consumed in the course of an oxidation 
 17 
 
reaction, the remaining phosphine oxide can be removed and the adduct is regenerated 
by stirring the phosphine oxide in a solution of excess H2O2 together with the 
corresponding ketone.  
 
Conclusion 
 Di(hydroperoxy)alkane adducts of phosphine oxides are successfully synthesized 
at room temperature, without the use of acid or metal catalysts. Phosphine, phosphine 
oxide, and H2O or H2O2 adducts of phosphine oxides can be used as the starting 
materials. While the high solubility of these starting materials make CH2Cl2 an attractive 
solvent, the corresponding ketone can be used as the solvent instead. This one-pot, 
general synthetic approach can be applied to a wide variety of phosphine oxides and 
ketones, and the resulting adducts can be safely and easily isolated in the form of large 
crystals.  
 
Experimental 
Ph3PO•(HOO)2CMe2 (4) 
Ph3P (200 mg, 0.762 mmol) is weighed into a Schlenk flask flushed with 
nitrogen gas. Acetone (100 mL) is added under a nitrogen flow. Once the phosphine is 
all dissolved, H2O2 (1.0 mL, 10 mmol) is added and the reaction mixture is stirred for 3 
h. The sample is concentrated in vacuo to 5 mL, then allowed to crystallize. 
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(Ph3PO)•(HOO)2CMe2 (4) is obtained as colorless rectangular crystals (243 mg, 0.629 
mmol, 82.5% yield).  
 
NMR (δ, CDCl3), 
31
P{
1
H} 34.74 (s); 
1
H 11.29-10.90 (br. s, -OOH), 7.68-7.61 (m, 6H, 
Ho), 7.60-7.55 (m, 3H, Hp), 7.51-7.46 (m, 6H, Hm), 1.47 (m, 6H, CH3); 
13
C{
1
H} 132. 57 
(s, Cp), 132.10 (d, 
2
J(
31
P-
13
C) = 10.7 Hz, Co), 130.56 (d, 
1
J(
31
P-
13
C) = 106.07 Hz, Ci), 
128.77 (d, 
3
J(
31
P-
13
C) = 12.6 Hz, Cm), 109.28 (s, CH3C), 20.64 (s, CH3). 
 
NMR (δ, (CD3)2CO), 
31
P{
1
H} 31.21 (s); 
1
H 10.97 (br. s, -OOH), 7.76-7.68 (m, 6H, Ho), 
7.67-7.62 (m, 3H, Hp), 7.60-7.53 (m, 6H, Hm), 1.35 (m, CH3); 
13
C{
1
H} 133.14 (d, 
4
J(
31
P-
13
C) = 2.3 Hz, Cp), 132.58 (d, 
2
J(
31
P-
13
C) = 10.2 Hz, Co), 132.51 (d, 
1
J(
31
P-
13
C) = 104.7 
Hz, Ci), 129.52 (d, 
3
J(
31
P-
13
C) = 12.1 Hz, Cm), 109.03 (s, CH3C), 20.97 (s, CH3). IR: 
ν(PO) = 1152 cm-1. mp (decomp.) 75 °C. 
 
Cy3PO•(HOO)2CMe2 (5) 
Cy3P (100 mg, 0.357 mmol) is weighed into a Schlenk flask inside a glove box. 
The flask is then sealed, brought outside, and acetone (60 mL) is added under a nitrogen 
flow. Once the phosphine is all dissolved, H2O2 (0.5 mL, 5.1 mmol) is added and the 
reaction mixture is stirred for 1 h. 100 mL of EtOH is then added to the flask, and the 
azeotropic mixture of EtOH and H2O is removed in vacuo at ambient temperature. 
(Cy3PO)•(HOO)2CMe2 (5) is obtained as colorless hexagonal crystals (126 mg, 0.327 
mmol, 91.6% yield) 
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NMR (δ, CDCl3), 
31
P{
1
H} 55.59 (s); 
1
H 1.97-1.80 (m, 15H, PCHaxCHeqCHeq), 1.77-1.70 
(s, 3H, PCH(CH2)2CHeq), 1.49-1.36 (s, 12H, PCHCHax, CH3), 1.36-1.21(m, 9H, 
PCHCH2CHaxCHax); 
13
C{
1
H} 108.91 (s, CH3C), 34.79 (d, 
1
J(
31
P-
13
C) = 60.9 Hz, PCH), 
26.74 (d, 
3
J(
31
P-
13
C) = 12.7 Hz, PCHCH2CH2), 25.98 (d, 
2
J(
31
P-
13
C) = 3.6 Hz, PCHCH2), 
25.92 (d, 
4
J(
31
P-
13
C) = 1.8 Hz, PCH(CH2)2CH2), 20.63 (s, CH3). 
 
NMR (δ, (CD3)2CO), 
31
P{
1
H} 56.44 (s); 
1
H 11.45 (br. s, -OOH), 2.02-1.89 (m, 9H, 
PCHaxCHeq), 1.86-1.76 (m, 6H, PCHCH2CHeq), 1.74-1.66 (m, 3H, PCH(CH2)2CHeq), 
1.52-1.38 (m, 6H, PCHCHax), 1.37-1.19 (m, 9H, PCHCH2CHaxCHax), 1.30 (s, CH3); 
13
C{
1
H} 108.61 (s, (CH3)2C(OOH)2), 35.53 (d, 
1
J(
31
P-
13
C) = 61.0 Hz, PCH), 27.36 (d, 
3
J(
31
P-
13
C) = 12.1 Hz, PCHCH2CH2), 26.74 (s, PCH(CH2)2CH2), 26.73 (d, 
2
J(
31
P-
13
C) = 
2.8 Hz, PCHCH2). IR: ν(PO) = 1125 cm
-1
. mp (decomp.) 70 °C. 
 
Ph3PO•(HOO)2CMeEt (6) 
Ph3P (300 mg, 1.1 mmol) was placed in a round bottom flask and dissolved in 
toluene (40 mL). 2-Butanone (0.12 mL, 1.3 mmol) and H2O2 (0.5 mL, 5 mmol) were 
added, and the reaction mixture was stirred overnight. The solution was concentrated to 
approximately 3 mL in vacuo and the product was allowed to crystallize. Adduct 6 was 
obtained in the form of colorless crystals (294 mg, 0.71 mmol, 65% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 30.52 (s); 
1
H 11.38 (s, 2H, OOH), 7.69-7.64 (m, 6H, Ho), 
7.60-7.55 (m, 3H, Hp), 7.51-7.46 (m, 6H, Hm), 1.79 (q, 
3
J(
1
H-
1
H) = 7.6 Hz, 2H, 
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CH2CH3), 1.41 (s, 3H, CCH3), 1.01 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 3H, CH2CH3); 
13
C{
1
H} 
132.32 (d, 
4
J(
31
P-
13
C) = 2.7 Hz, Cp), 132.08 (d, 
2
J(
31
P-
13
C) = 10.0 Hz, Co), 131.29 (d, 
1
J(
31
P-
13
C) = 105.4 Hz, Ci), 128.66 (d, 
3
J(
31
P-
13
C) = 12.3 Hz, Cm), 111.56 (s, CH3C), 
26.09 (s, CH2CH3), 17.46 (s, CCH3), 8.38 (s, CH2CH3).  
 
NMR (δ, C6D6), 
31
P{
1
H} 31.42 (s); 
1
H 11.95 (s, 2H, OOH), 7.62-7.56 (m, 6H, Ho), 7.03-
6.98 (m, 3H, Hp), 6.96-6.91 (m, 6H, Hm), 2.09 (q, 
3
J(
1
H-
1
H) = 7.6 Hz, 2H, CH2CH3), 
1.65 (s, 3H, CCH3), 1.11 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 3H, CH2CH3); 
13
C{
1
H} 132.32 (d, 
2
J(
31
P-
13
C) = 10.4 Hz, Co), 132.11 (d, 
1
J(
31
P-
13
C) = 104.0 Hz, Ci), 132.10 (d, 
4
J(
31
P-
13
C) 
= 3.2 Hz, Cp), 128.72 (d, 
3
J(
31
P-
13
C) = 12.3 Hz, Cm), 111.70 (s, CH3C), 26.94 (s, 
CH2CH3), 18.16 (s, CCH3), 8.78 (s, CH2CH3). IR: ν(PO) = 1142 cm
-1
. mp (decomp.) 
54 °C. 
 
Cy3PO•(HOO)2CMeEt (7)  
[Cy3PO•H2O2]2 (300 mg, 0.91 mmol) was placed in a round bottom flask and 
dissolved in 30 mL of butanone (0.33 mol). After addition of H2O2 (0.5 mL, 5 mmol) the 
solution was stirred overnight. Excess butanone was removed in vacuo until a precipitate 
appeared. Subsequently, 50 mL of EtOH was added to the flask, and the azeotropic 
mixture of EtOH and H2O was removed in vacuo at ambient temperature to give white 
crystals of 7 (345 mg, 0.82 mmol, 90% yield).  
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NMR (δ, CDCl3), 
31
P{
1
H} 58.77 (s); 
1
H 11.47 (s, 2H, OOH), 1.97-1.80 (m, 15H, 
PCHCHeqCHeq), 1.73 (q, 
3
J(
1
H-
1
H) = 7.6 Hz, 2H, CH2CH3), 1.76-1.72 (m, 3H, 
PCH(CH2)2CHeq), 1.48-1.39 (m, 6H, PCHCHax), 1.38 (s, 3H, CCH3), 1.29-1.23 (m, 9H, 
PCHCH2CHaxCHax), 0.97 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 3H, CH2CH3); 
13
C{
1
H} 111.26 (s, 
CH3C), 34.72 (d, 
1
J(
31
P-
13
C) = 60.5 Hz, PC), 26.72 (d, 
3
J(
31
P-
13
C) = 12.1 Hz, 
PCHCH2CH2), 26.02 (s, CH2CH3),  25.96 (d, 
2
J(
31
P-
13
C) = 2.8 Hz, PCHCH2), 25.91 (d, 
4
J(
31
P-
13
C) = 1.4 Hz, PCH(CH2)2CH2), 17.41 (s, CCH3), 8.36 (s, CH2CH3). IR: ν(PO) = 
1124 cm
-1
. mp (decomp.) 108 °C. 
 
Cy3PO•(HOO)2CEt2 (8) 
[Cy3PO•H2O2]2 (330 mg, 1.0 mmol) was placed in a round bottom flask and 
combined with 3-pentanone (0.4 mL, 2 mmol) and H2O2 (0.2 mL, 2 mmol). The mixture 
was stirred for 1 h, then left to crystallize by slow evaporation of solvent. 
Cy3PO•(HOO)2CEt2 (8) was obtained in the form of white, rod-shaped crystals (425 mg, 
1.0 mmol, 98% yield).  
 
NMR (δ, CDCl3), 
31
P{
1
H} 58.35 (s); 
1
H 10.82 (br. s, 2H, OOH), 1.96-1.81 (m, 15H, 
PCHaxCHeqCHeq), 1.76-1.71 (m, 3H, PCH(CH2)2CHeq), 1.81 (t, 
3
J(
1
H-
1
H) = 6.4 Hz, 4H, 
CCH2), 1.68 (q, 
3
J(
1
H-
1
H) = 7.6 Hz, 4H, CCH2), 1.47-1.37 (m, 8H, PCHCHax, 
CCH2CH2CH2), 1.30-1.22 (m, 9H, PCHCH2CHaxCHax), 0.94 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 6H, 
CCH2CH3); 
13
C{
1
H} 113.76 (s, CCH3), 34.64 (d, 
1
J(
31
P-
13
C) = 60.5 Hz, PC), 26.68 (d, 
3
J(
31
P-
13
C) = 11.6 Hz, PCHCH2CH2), 25.93 (d, 
2
J(
31
P-
13
C) = 3.3 Hz, PCHCH2), 25.87 (d, 
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4
J(
31
P-
13
C) = 0.9 Hz, PCH(CH2)2CH2), 21.64 (s, CH2CH3), 7.91 (s, CH2CH3). IR: ν(PO) 
= 1126 cm
-1
. mp 138 °C.  
 
Cy3PO•(HOO)2C(CH2)4 (9) 
In a round bottom flask [Cy3PO•H2O2]2 (996 mg, 3 mmol) is dissolved in 
cyclopentanone (4.6 mL, 52 mmol). H2O2 (1 mL, 10 mmol) is added to the flask, the 
contents is stirred for 1 h, then left to crystallize by slow evaporation of the solvent. 
Cy3PO•(HOO)2C(CH2)4 (9) is obtained in the form of colorless, cubic crystals (1049 mg, 
2.3 mmol, 76% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 57.14 (s); 
1
H 11.61 (br. s, 2H, OOH), 1.93 (t, 4H, 
3
J(
1
H-
1
H) = 
7.58 Hz, CCH2), 1.95-1.81 (m, 15H, PCHaxCHeqCHeq), 1.75-1.71 (m, 3H, 
PCH(CH2)2CHeq), 1.70 (t, 4H, 
3
J(
1
H-
1
H) = 7.58 Hz, CCH2CH2), 1.47-1.37 (m, 6H, 
PCHCHax), 1.31-1.21 (m, 9H, PCHCH2CHaxCHax); 
13
C{
1
H} 120.92 (s, CCH3), 34.80 (d, 
1
J(
31
P-
13
C) = 60.5 Hz, PC), 33.14 (s, CCH2), 26.76 (d, 
3
J(
31
P-
13
C) = 11.6 Hz, 
PCHCH2CH2), 26.01 (d, 
2
J(
31
P-
13
C) = 3.3 Hz, PCHCH2), 25.95 (d, 
4
J(
31
P-
13
C) = 1.4 Hz, 
PCH(CH2)2CH2), 24.66 (s, CCH2CH2). IR: ν(PO) = 1123 cm
-1
. mp 152 °C. 
 
Cy3PO•(HOO)2C(CH2)5  (10)  
0.3 mL of H2SO4 (5 mmol) and 13.5 mL of H2O2 (0.135 mol) were combined 
with THF (25 mL) in a round bottom flask. Cyclohexanone (1.00 mL, 9.7 mmol) was 
added dropwise over a period of 15 min, while stirring vigorously. After 5 h, 10 mL of 
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CH2Cl2 was added, and NaHCO3 was used to neutralize the mixture to pH 7. The 
organic layer was collected, washed with H2O (4x3 mL) and dried with MgSO4. Solvent 
from the filtrate was removed in vacuo, to produce (HOO)2C(CH2)5. The 
1
H and 
13
C 
NMR spectra of (HOO)2C(CH2)5 matched those in the literature.
23a
 [Cy3PO•H2O2]2 (297 
mg, 0.9 mmol) was dissolved in 5 mL of benzene and added to the flask. The mixture 
was stirred for 2 h and subsequently concentrated in vacuo to about 2 mL at ambient 
temperature. Cy3PO•(HOO)2C(CH2)5 (10) was obtained as clear, hexagonal crystals (235 
mg, 0.53 mmol, 59% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 58.01 (s); 
1
H 10.66 (br. s, 2H, OOH), 1.97-1.79 (m, 15H, 
PCHaxCHeqCHeq), 1.81 (t, 
3
J(
1
H-
1
H) = 6.4 Hz, 4H, CCH2), 1.75-1.71 (m, 3H, 
PCH(CH2)2CHeq), 1.58 (quin, 
3
J(
1
H-
1
H) = 6.4 Hz, 4H, CCH2CH2), 1.47-1.37 (m, 8H, 
PCHCHax, CCH2CH2CH2), 1.31-1.22 (m, 9H, PCHCH2CHaxCHax); 
13
C{
1
H} 109.52 (s, 
CCH3), 34.67 (d, 
1
J(
31
P-
13
C) = 60.5 Hz, PC), 29.68 (s, CCH2), 26.69 (d, 
3
J(
31
P-
13
C) = 
12.1 Hz, PCHCH2CH2), 25.94 (d, 
2
J(
31
P-
13
C) = 3.3 Hz, PCHCH2), 25.89 (d, 
4
J(
31
P-
13
C) 
= 0.9 Hz, PCH(CH2)2CH2), 25.55 (s, CCH2CH2CH2), 22.53 (s, CCH2CH2). IR: ν(PO) = 
1123 cm
-1
.  mp 121 °C.  
 
Cy3PO•(HOO)2C(CH2)6 (11) 
[Cy3PO•H2O2]2 (831 mg, 2.5 mmol), dissolved in cycloheptanone (3.0 mL, 25 
mmol), is placed into a round bottom flask. H2O2 (1 mL, 10 mmol) is added to the flask, 
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the contents is stirred for 1 h, and then left to crystallize. Cy3PO•(HOO)2C(CH2)6 (11) is 
obtained in the form of colorless, cubic crystals (1067 mg, 2.2 mmol, 88% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 56.63 (s); 
1
H 11.57 (br. s, 2H, OOH), 1.93-1.81 (m, 19H, 
PCHaxCHeqCHeq, CCH2), 1.75-1.71 (m, 3H, PCH(CH2)2CHeq), 1.61-1.53 (m, 
CCH2CH2CH2), 1.47-1.36 (m, 6H, PCHCHax), 1.31-1.21 (m, 9H, PCHCH2CHaxCHax); 
13
C{
1
H} 114.33 (s, CCH3), 34.80 (d, 
1
J(
31
P-
13
C) = 60.9 Hz, PC), 32.36 (s, CCH2), 30.23 
(s, CCH2CH2), 26.75 (d, 
3
J(
31
P-
13
C) = 11.6 Hz, PCHCH2CH2), 26.00 (d, 
2
J(
31
P-
13
C) = 
2.7 Hz, PCHCH2), 25.95 (d, 
4
J(
31
P-
13
C) = 0.9 Hz, PCH(CH2)2CH2), 22.84 (s, 
CCH2CH2CH2). IR: ν(PO) = 1123 cm
-1
.  mp 138 °C. 
 
Cy3PO•(HOO)2CMePh (12)  
[Cy3PO•H2O2]2 (425 mg, 1.30 mmol) was dissolved in 3 mL of acetophenone 
(25.7 mmol) in a round bottom flask. Then, H2O2 (1.3 mL, 130 mmol) was added, and 
the solution was stirred for 4 h. The solution was concentrated in vacuo to about 3 mL, 
then allowed to crystallize. Cy3PO•(HOO)2CMePh (12) was obtained in the form of 
colorless crystals (327 mg, 0.70 mmol, 54%). 
 
31
P{
1
H} NMR (δ, CDCl3), 
31
P 58.31 (s); 
1
H 11.89 (br. s, 2H, OOH), 7.59-7.56 (m, 2H, 
Ho), 7.38-7.33 (m, 2H, Hm), 7.31-7.27 (m, 1H, Hp), 1.94-1.80 (m, 15H, PCHaxCHeqCHeq), 
1.75-1.71 (m, 3H, PCH(CH2)2CHeq), 1.66 (s, 3H, CH3), 1.47-1.37 (m, 6H, PCHCHax), 
1.30-1.20 (m, 9H, PCHCH2CHaxCHax); 
13
C{
1
H} 140.09 (s, Ci), 127.98 (s, Co), 127.82 (s, 
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Cp), 125.94 (s, Cm), 110.18, (S, CCH3), 34.68 (d, 
1
J(
31
P-
13
C) = 60.5 Hz, PC), 26.70 (d, 
3
J(
31
P-
13
C) = 12.1 Hz, PCHCH2CH2), 25.95 (d, 
2
J(
31
P-
13
C) = 3.3 Hz, PCHCH2), 25.89 (d, 
4
J(
31
P-
13
C) = 1.4 Hz, PCH(CH2)2CH2), 23.40 (CCH3). IR: ν(PO) = 1123 cm
-1
. mp 
(decomp.) 100 °C. 
 
Ph2P(O)CH2P(O)Ph2•(HOO)2CMe2 (13)  
In a round bottom flask Ph2PCH2PPh2 (384 mg, 1 mmol) was dissolved in 60 mL 
of CH2Cl2. Then H2O2 (0.5 mL, 5 mmol) was added, and the solution was stirred for 1 h. 
The organic layer was collected in a separation funnel, and the solvent was removed in 
vacuo. The resulting white precipitate (Ph2P(O)CH2P(O)Ph2) was dissolved in 5 mL of 
acetone, and after the addition of another 0.5 mL of H2O2, the sample was allowed to 
crystallize via slow evaporation of the solvent. Adduct 14 was obtained in the form of 
white, needle-like crystals (364 mg, 0.76 mmol, 76% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 30.33 (s); 
1
H 11.01 (br. s, 2H, OOH), 7.72-7.66 (m, 8H, Ho), 
7.47-7.42 (m, 4H, Hp), 7.38-7.33 (m, 8H, Hm), 3.62 (t, 
3
J(
31
P-
1
H) = 14.7 Hz, 2H, PCH2), 
1.48 (s, 6H, CCH3); 
13
C{
1
H} 132.21 (s, Cp), 131.07 (d, 
1
J(
31
P-
13
C) = 107.0 Hz, Ci), 
130.86 (virtual quintet, J(
31
P-
13
C) = 5.1 Hz, Co), 128.64 (virtual quintet, J(
31
P-
13
C) = 6.1 
Hz, Cm), 109.21 (s, CCH3), 21.26 (PCH2), 20.63 (s, CCH3).  
 
NMR (δ, (CD3)2CO), 
31
P{
1
H} 26.63 (s); 
1
H 10.49 (br. s, OOH), 7.87-7.81 (ddd, 
3
J(
31
P-
1
H) = 12.2 Hz, 
3
J(
1
H-
1
H) = 8.3 Hz, 
4
J(
1
H-
1
H) = 1.2 Hz, Ho), 7.52-7.47 (td 
3
J(
1
H-
1
H) = 
 26 
 
7.3 Hz, 
4
J(
1
H-
1
H) = 1.2 Hz, Hp), 7.43-7.38 (td 
3
J(
1
H-
1
H) = 8.3 Hz, 
3
J(
1
H-
1
H) = 7.3 Hz, 
Hm), 3.99 (t, 
2
J(
31
P-
1
H) = 13.9 Hz, -CH2-), 1.36 (s, -CH3); 
13
C{
1
H} 133.46 (d, 
1
J(
31
P-
13
C) 
= 106.2 Hz, Ci), 131.74 (s, Cp), 130.89 (virtual quintet 29.3 Hz, Co), 128.38 (virtual 
quintet, 30.5 Hz, Cm), 108.34 (s, CH3C), 20.43 (s, PCH2), 20.25 (s, -CH3). IR: ν(PO) = 
1163.1 cm
-1
. mp (decomp.) 120 °C. 
 
(Ph2P(O)CH2CH2P(O)Ph2)•((HOO)2CMe2)2 (14)  
 Ph2P(O)CH2CH2P(O)Ph2 (20 mg, 0.05 mmol) was dissolved in 0.5 mL of 
acetone (6.8 mmol) in a round bottom flask. Subsequently, H2O2 (0.1 mL, 1 mmol) was 
added and the solution was stirred for 1 h, then left to crystallize via slow evaporation of 
the solvent. Adduct 14 crystallized in the form of colorless, needle-like crystals (27 mg, 
0.04 mmol, 84% yield). 
 
NMR (δ, CDCl3),
 31
P{
1
H} 38.78 (s); 
1
H 11.34 (s, 2H, OOH), 7.71 (dd, 8H, 
3
J(
31
P-
1
H) = 
11.5 Hz, 
3
J(
1
H-
1
H) = 7.3 Hz, Ho), 7.52 (t, 4H, 
3
J(
1
H-
1
H) = 7.3 Hz, Hp), 7.45 (dd, 8H, 
3
J(
1
H-
1
H) = 11.5 Hz, 
3
J(
1
H-
1
H) = 7.3 Hz, Hm), 2.52 (d, 4H, 
2
J(
31
P-
1
H) = 2.5 Hz, PCH2-), 
1.51 (s, 12H, -CH3);  
13
C{
1
H} = 132.70 (s, Cp), 130.68 (virtual triplet, J(
31
P-
13
C) = 4.9 
Hz, Co), 129.86 (d, 
1
J(
31
P-
13
C) = 100.0 Hz, Ci), 129.21 (virtual triplet, J(
31
P-
13
C) = 6.1 
Hz, Cm), 109.38 (s, CH3C), 21.08 (virtual triplet, J(
31
P-
13
C) = 33.0 Hz, PCH2), 20.68 (s, -
CH3). IR: ν(PO) = 1148 cm
-1
. mp (decomp.) 80 °C.  
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(Ph2P(O)CH2CH2P(O)Ph2)•((HOO)2CEt2)2 (15)  
Ph2P(O)CH2CH2P(O)Ph2 (20 mg, 0.05 mmol) was dissolved in 0.3 mL of 
pentanone (2.8 mmol) in a round bottom flask. Subsequently, H2O2 (0.1 mL, 1 mmol) 
was added and the solution was stirred for 1 h, then left to crystallize via slow 
evaporation of the solvent. Adduct 15 crystallized in the form of colorless, needle-like 
crystals (22 mg, 0.04 mmol, 78% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 39.42 (s); 
1
H 10.81 (virtual doublet, J(
31
P-
1
H = 82.2 Hz, 2H, 
OOH), 7.81-7.75 (m, 8H, Ho), 7.58-7.53 (m, 4H, Hp), 7.51-7.46 (m, 8H, Hm), 2.66 (d, 
3
J(
31
P-
1
H) = 2.7 Hz, 2H, PCH2), 1.75 (q, 
3
J(
1
H-
1
H) = 7.6 Hz, 8H, CH2CH3), 1.00 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 12H, CH2CH3); 
13
C{
1
H} 132.74 (s, Cp), 130.67 (virtual quintet, 
J(
31
P-
13
C) = 5.1 Hz, Co), 129.61 (d, 
1
J(
31
P-
13
C) = 102.8 Hz, Ci), 129.23 (virtual quintet, 
J(
31
P-
13
C) = 6.1 Hz, Cm), 114.13 (s, CCH3), 21.81 (s, CH2CH3), 21.05 (virtual triplet, 
J(
31
P-
13
C) = 33.0 Hz, PCH2), 7.99 (s, CH3). IR: ν(PO) = 1150 cm
-1
. mp (decomp.) 82 °C.  
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CHAPTER IV  
CHARACTERIZATION OF THE ADDUCTS R3PO•(HOO)2CR'R"

 
 
Introduction 
It is known that acetone and hydrogen peroxide can form triacetone triperoxide 
(TATP) and other oligomers in the presence of acid, which can be explosive in the solid 
form.
26-27
 Because both acetone and hydrogen peroxide are involved in the synthesis of 
the first few adducts, it was important to have analytical tools for determining the 
identity of the product in solution, prior to crystallization. NMR spectroscopy is 
especially useful in this respect, and attention is given to some of these characterization 
data, as they can be used diagnostically during the synthesis, prior to isolation of the 
product.  
In an FT-IR spectrum, the characteristic peroxide band ν(O-H) is easily 
differentiable from the broad water band ν(O-H). Therefore, IR spectroscopy can be 
used as a quick analytical check for confirming the absence of water in the material prior 
to applying the adduct in organic reactions.  
Single crystal X-ray crystallography allows for exact structural determination of 
these adducts, as well as providing information regarding the phosphine oxide to 
                                                 

 Reproduced with permission from “Hydrogen Peroxide and Di(hydroperoxy)propane Adducts of 
Phosphine Oxides as Stoichiometric and Soluble Oxidizing Agents” Ahn, S. H.; Cluff, K. J.; 
Bhuvanesh, N.; Blümel, J. Angew. Chem. 2015, 127, 13539-13543. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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(HOO)2CR'R" ratio. A trend with respect to the elongation of the P=O bond length is 
also observed with the increase of the number of hydrogen bonds and their strengths.  
The characteristic signals in each of these analytical methods are unique to the 
R3PO•(HOO)2CR'R" adducts. Thus, the properties of the newly discovered adducts are 
studied via multinuclear NMR spectroscopy, single crystal X-ray crystallography and IR 
spectroscopy, and the results of these analyses are described in detail. 
 
Results and Discussion 
All adducts 4-15 have been obtained in the form of large single crystals, and they 
have been characterized with single crystal X-ray crystallography (Figure 4.1, Figure 
4.2).  
 
 
Figure 4.1. Large single crystals of (a) 4, (b) 9, (c) 10, and (d) 11. 
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Figure 4.2. Single crystal X-ray structures of adducts 4-15.
28-40
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For monodentate phosphine oxides, X-ray structures of the adducts 4-12
28-37
 
confirm that each P=O group forms two hydrogen bridges to one (HOO)2CR'R" moiety. 
This means that there are two active oxygen atoms per P=O group, and thus the molar 
ratio of active peroxide is twice as high as for the H2O2 adducts presented previously.
6,18
 
This is also true for the bidentate dppe dioxide. Each P=O group forms two hydrogen 
bonds, with both (HOO)2CMe2 (14)
38
 and (HOO)2CEt2 (15).
39
  
Regarding the dppm dioxide, however, only one of the two P=O groups is 
bonded to the (HOO)2CMe2 moiety (13).
40
 The two P=O groups are only separated by 
one methylene group, and thus the interaction with a second (HOO)2CMe2 unit may be 
sterically hindered. The distances between the two P=O oxygen atoms and the terminal 
oxygen atom of one OOH group are practically identical with 2.816 and 2.817 Å  (Figure 
4.3). Therefore, one could imagine that the hydrogen atom interacts with both P=O 
oxygen atoms equally.  
 
 32 
 
 
Figure 4.3. X-ray structure of 13 with corresponding bond distances. Only the 
hydrogen-bonded H atoms and ipso carbon atoms of the phenyl rings are shown for 
clarity.
40
 
 
 
However, the P=O bond lengths differ. The P=O bond of the group carrying the 
adduct is lengthened to 1.495 Å , while the free P=O bond remains in the typical range of 
undisturbed P=O bond lengths with 1.488 Å , and thus the interaction of the proton with 
both P=O groups is not likely in the solid state.
17
 As for adducts 4-12 and 14-15, a 
significant elongation of the P=O bond is observed between neat phosphine oxide and 
adducts as a result of hydrogen bonding (Table 4.1). 
 
 
 
 
 33 
 
Table 4.1. Comparison of the P=O bond lengths of the pure phosphine oxides Ph3PO, 
Cy3PO, Ph2P(O)CH2P(O)Ph2 and Ph2P(O)CH2CH2P(O)Ph2 with the adducts 4-15. 
 
Species P=O bond length (Å) Δ Bond length 
4 1.502 +0.023 
5 1.507 +0.017 
6 1.507/1.505 +0.017/0.015 
7 1.510 +0.020 
8 1.508 +0.018 
9 1.513 +0.023 
10 1.512 +0.022 
11 1.505 +0.015 
12 1.510 +0.020 
13 
1.488/1.495 
average: 1.492 
+0.001 
14 1.505 +0.015 
15 1.501 +0.011 
Ph3PO 1.479
41
 - 
Cy3PO 1.490
42
 - 
Ph2P(O)CH2P(O)Ph2 1.491
43
 - 
Ph2P(O)CH2CH2P(O)Ph2 average: 1.490
44
 - 
 
 
In determining whether the reaction product is safe to isolate and crystallize, 
13
C 
NMR spectroscopy is especially useful, as the signal of the quaternary carbon nucleus in 
the (HOO)2CR'R" moieties occurs in a narrow range and unique region (108-120 ppm) 
of the carbon spectrum and can therefore be used as a diagnostic signal (Figure 4.4, 
 34 
 
Table 4.2).
18
 In the case of shock-sensitive DADP (diacetone diperoxide) or TATP, the 
quaternary peak appears more upfield shifted, at about 105 ppm.
26
 
 
 
Figure 4.4. 
13
C NMR spectrum of Ph3PO•(HOO)2CMe2 in CDCl3. 
 
 
Table 4.2. 
13
C NMR Chemical shifts of the quaternary carbon signals of the adducts 
R3PO• (HOO)2CR'R" in CDCl3. 
 
Adduct Cq (ppm) Adduct Cq (ppm) 
4 109.28 10 109.52 
5 108.91 11 114.34 
6 111.56 12 110.18 
7 111.26 13 109.21 
8 113.76 14 109.38 
9 120.92 15 114.13 
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The 
31
P NMR signals of the adducts R3PO•(HOO)2CR'R" are shifted downfield 
as compared to the neat phosphine oxides R3PO (Table 4.3).
18
 This downfield shift is 
caused by the decrease in electron density around the phosphorus nucleus of the P=O 
group, as the electrons get pulled towards the oxygen atom to support the hydrogen 
bonds. The change in the 
31
P chemical shift is most significant for Cy3PO, with Δδ being 
larger than 6 ppm in most cases.  
 
Table 4.3. 
31
P NMR chemical shifts for the adducts R3PO•(HOO)2CR'R" and the 
corresponding neat R3PO in CDCl3. The differences are given as Δδ (ppm). 
 
Adduct δ(31P) (ppm) Δδ (ppm) 
4 34.74 5.64 
5 55.59 5.68 
6 30.52 1.42 
7 58.77 8.86 
8 58.35 8.44 
9 57.14 7.23 
10 58.01 8.10 
11 56.63 6.72 
12 58.31 8.40 
13 30.33 5.47 
14 38.78 6.10 
15 39.42 6.74 
Ph3PO 29.16 - 
Cy3PO 49.91 - 
Ph2P(O)CH2P(O)Ph2 24.86 - 
Ph2P(O)CH2CH2P(O)Ph2 32.68 - 
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 Many of these adducts could easily be obtained as large single crystals (Figure 
4.1). This rare opportunity could be seized to perform single crystal solid-state NMR 
measurements of 4. The chemical shift anisotropy (CSA) obtained from the span of the 
31
P wideline NMR spectrum of polycrystalline 4 amounts to 166 ppm (Figure 4.5).
18
  
 
 
 
Figure 4.5. 
31
P CP wideline NMR spectrum of polycrystalline 4. The CSA, defined as 
the span of the signal, δ11-δ33, amounts to 166.3 ppm. δ11 = 95.4, δ22 = 85.0, δ33 = -70.9, 
δiso = 36.5 ppm.
18
 
 
 
Figure 4.6 displays the 
31
P CP spectra of a single crystal of 4 recorded with 
different random orientations. The random orientations were obtained by ejecting and 
reinserting the rotors into the probehead. Two resonances, corresponding to two 
magnetically inequivalent 
31
P nuclei in the unit cell, are obtained in most cases. The two 
resonances can overlap by accident, but this event is statistically less favored. The 
chemical shift changes of the two signals with the orientation of the crystal in the 
external magnetic field are different, as expected and described for other cases.
17,45
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Figure 4.6. 
31
P CP NMR spectra of a large single crystal of 4 at different random 
orientations with respect to the external magnetic field. 
 
 
For adduct 5, all protons of the adducts are accounted for in the 
1
H NMR spectra, 
and all signals have been successfully assigned with the help of 2-dimensional 
13
C,
1
H 
COSY NMR spectroscopy (Figure 4.7, Figure A.18). While the peroxide protons appear 
downfield shifted to about 11.5 ppm (Table 4.4), the absence of any obvious water signal 
corroborates the assumption that the sample is water-free (Figure 4.7).  
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Figure 4.7. 
1
H NMR spectrum of 5 in CDCl3, with complete signal assignment. The 
peroxide proton peak is visible at 11.45 ppm.  
 
 
Table 4.4. 
1
H Chemical shifts of the peroxide protons of the adducts 4-15. 
 
Adduct δ(1H) OOH (ppm) Adduct δ(1H) OOH (ppm) 
4 11.15 10 10.66 
5 11.45 11 11.57 
6 11.38 12 11.89 
7 10.90 13 10.73 
8 10.82 14 11.28 
9 11.61 15 10.81 
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Additionally, the IR spectra of 4-15 show no H2O hydroxyl stretching band at 
3400 cm
-1 
(Figure B.5-Figure B.18), and thus it can be confirmed that no water is present 
in these adducts.
6
 Instead, all adducts display a broad band around 3200 cm
-1
, 
corresponding to the hydroperoxy stretching band ν(O-H) (Table 4.5).  
 
Table 4.5. Stretching bands ν(O-H), ν(C-O), ν(O-O) and comparison of the ν(P=O) IR 
values of the pure phosphine oxides with those of the adducts 4-15, given as Δν(P=O). 
 
Species 
ν(O-H) 
(cm
-1
) 
ν(P=O) 
(cm
-1
) 
ν(C-O) 
(cm
-1
) 
ν(O-O) 
(cm
-1
)
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Δν(P=O) 
(cm
-1
) 
4 3256 1152 1118 885 30 
5 3192 1125 1099 891, 856 32 
6 3250 1142 1118 889, 851 40 
7 3196 1124 1101 893, 854 33 
8 3194 1126 1103 891, 858 31 
9 3167 1123 1101 891, 860 34 
10 3196 1123 1103 893, 860 34 
11 3186 1123 1101 891, 856 34 
12 3176 1123 1101 889, 851 34 
13 3291 1163 1099 871 25 
14 3242 1148 1097 872 24 
15 3275 1150 1097 858 22 
Ph3PO - 1182 - - - 
Cy3PO - 1157
1
 - - - 
Ph2P(O)CH2P(O)Ph2 - 1188 - - - 
Ph2P(O)CH2CH2P(O)Ph2 - 1172 - - - 
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Representative FT-IR spectra of 6 and 7 are shown in Figure 4.8. In general, the 
P=O band is observed around 1150 cm
-1
 for aryl phosphine oxide adducts and 1120 cm
-1
 
for Cy3PO adducts (Table 4.5). 
 
 
Figure 4.8. Representative IR spectra of adduct 4 (top) and 5 (bottom). 
 
 
The ν(P=O) bands of the adducts 4-15 are lower in frequency as compared to the 
neat R3PO analogs, due to the P=O bond strength being weakened by the hydrogen 
bonds. The change in wavenumber is similar for most of the R3PO adducts incorporating 
one PO group, with a shift of 30-34 cm
-1
. The red shift is less significant for the adducts 
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13-15 with two PO bonds each, which agrees with the smaller change in P=O bond 
lengths of the adducts 13-15 (Table 4.1). The ν(P=O) stretching bands for Cy3PO 
adducts often overlap with strong ν(C-O) bands that occur around 1101 cm-1. Finally, the 
ν(O-O) stretching frequency can be observed as sharp signals around 890 and 860 cm-1, 
as expected (Table 4.5), the only problem being potential overlap with other fingerprint 
IR absorptions in this region.
46-47
  
 
Conclusion 
 
13
C NMR spectroscopy is an excellent tool for confirming the synthesis of a new 
adduct prior to its isolation. The diagnostic signal at 108-120 ppm in CDCl3 is unique to 
a quaternary carbon bound to two peroxide functionalities, and yet is different enough 
from the quaternary carbon of the shock-sensitive oligomers DADP or TATP. At this 
point, no specific trend is observed between the changing R' and R" groups of the moiety 
(HOO)2CR'R" and the shift in the quaternary signal.  
 Single crystal X-ray crystallography provides indisputable proof that the adducts 
are systematic molecule-type assemblies with an exact ratio between the phosphine 
oxide groups and the (HOO)2CR'R" moieties. Significant P=O bond elongation is 
observed in connection with the formation of multiple hydrogen bonds.  
 The weakened P=O bond strength is also observed in the IR spectra, as the 
ν(P=O) bands undergo red shifts of around 30 cm-1. Along with the 1H NMR peaks at 
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10-11 ppm, the peroxide ν(O-H) stretching bands around 3200 cm-1 in the IR spectra 
confirm the presence of peroxide protons in the adduct molecules.  
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CHAPTER V  
SOLUBILITY STUDY

 
 
Introduction 
 In Chapter II, it was mentioned that one of the most important advantages of the 
hydrogen peroxide adducts [R3PO•H2O2]2 with respect to their application as oxidizing 
agents is that they are very soluble in organic solvents, rendering biphasic reaction 
mixtures obsolete. The same is true for the adducts R3PO•(HOO)2CR'R" (R, R', R" = 
alkyl, aryl), and therefore the solubilities of selected adducts in common organic 
solvents were quantified.  
 
Results and Discussion 
 The solubilities of the adducts in organic solvents are measured by dissolving 20 
mg of each adduct in the determined minimum amount of solvent, and measuring the 
mass of the solvent upon complete solvation. The results of the solubility tests for the 
representative adducts 4-11 are summarized in Figure 5.1. The solubilities are 
remarkably high in chloroform and dichloromethane, but even in aromatic solvents such 
as toluene and benzene, the solubilities are substantial.  
                                                 

 Reproduced with permission from “Hydrogen Peroxide and Di(hydroperoxy)propane Adducts of 
Phosphine Oxides as Stoichiometric and Soluble Oxidizing Agents” Ahn, S. H.; Cluff, K. J.; 
Bhuvanesh, N.; Blümel, J. Angew. Chem. 2015, 127, 13539-13543. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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Figure 5.1. Solubilities of the adducts 4-11 in common organic solvents. 
 
  
The total concentration of active peroxide in a sample solution can be increased 
even more by dissolving two or more adducts with different phosphine oxides in the 
same solution. For instance, 20 mg of 6 and 20 mg of 7 were both dissolved together in a 
minimum amount of CH2Cl2 (84 mg, 0.063 mL). Therefore, in this mixture, 6 and 7 each 
display a solubility of 317 mg/mL, for a total of 3.0 M concentration of active peroxide 
in CH2Cl2. When compared to the individual solubilities of 636 mg/mL of 6 and 374 
mg/mL of 7 in CH2Cl2 (Figure 5.1), the solubilities of the mixture of 6 and 7 appear 
reduced. However, the 3.0 M concentration of active peroxide is comparable to that of 7 
(3.18 M in CH2Cl2), and significantly increased compared to 6 (1.79 M in CH2Cl2). 
Therefore, the mixture contains overall a much higher concentration of peroxide than 
each single component by itself. 
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In an analogous experiment, 19 mg of 7 were dissolved in a minimum amount of 
CH2Cl2 (27 mg, 0.05 mL). To this completely saturated solution, a powder sample of 6 
was added in very small portions and the mixture was swirled to facilitate dissolution. 
The process was continued until the powder did not dissolve anymore, at which point a 
total of 17 mg of 6 had been added. In this mixture, the solubility of 6 was 333 mg/mL 
and 7 was 374 mg/mL, for a combined concentration of 3.4 M active peroxide in CH2Cl2. 
This is in the same order of magnitude as the 35 wt% aqueous H2O2, with a 10 M 
concentration of active peroxide.  
As evidenced from these two tests, the saturation with one adduct does not 
completely prohibit the dissolution of another adduct in the same sample, although the 
solubility of the second adduct may be decreased as compared with its solubility in 
pristine solvent.  
 
Conclusion 
 Similar to the H2O2 adducts of phosphine oxides, the adducts of the type 
R3PO•(HOO)2CR'R" (R, R', R" = alkyl, aryl) display high solubility in common organic 
solvents. The concentration of active peroxide can be increased even more by combining 
adducts of multiple different phosphine oxides. When applied to organic reactions, these 
adducts are very appealing, as the reactions can be performed in one phase, and the 
volume of solvent can be decreased to reduce costs.  
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CHAPTER VI  
SHELF LIFE AND DECOMPOSITION STUDY

 
 
Introduction 
 Aqueous H2O2 gradually decomposes to form oxygen gas and H2O. Therefore, 
aqueous H2O2 is often administered in excess because the oxidant decomposes at 
unpredictable rates, and thus the concentration at any given time is unknown. For 
applications requiring exact stoichiometry, the solution has to be titrated prior to use.
7
  
 In the case of the adducts R3PO•(HOO)2CR'R" (R, R', R" = alkyl, aryl) the 
hydrogen bonds between the peroxide and the phosphine oxide groups do not break 
easily, and therefore the phosphine oxides act as stable, solid carriers of the peroxide. 
However, in order to ensure accurate stoichiometry at the time of use, the study of 
stability and shelf life of the adducts is essential. Decomposition of these adducts occurs 
via the release of oxygen gas from the peroxide functionality.
8c,48
 In addition to shelf life, 
the safety of these adducts during decomposition was of interest, and thus the adducts 
were exposed to mechanical and thermal stress on a small scale.   
In this chapter, the results of the decomposition tests are reported, and a 
quantitative NMR (QNMR) method is described in which 
31
P NMR spectroscopy is 
utilized to determine the % decomposition of active peroxide in the adducts over time.
49
  
                                                 

 Reproduced with permission from “Hydrogen Peroxide and Di(hydroperoxy)propane Adducts of 
Phosphine Oxides as Stoichiometric and Soluble Oxidizing Agents” Ahn, S. H.; Cluff, K. J.; 
Bhuvanesh, N.; Blümel, J. Angew. Chem. 2015, 127, 13539-13543. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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In order to determine the number of active peroxide groups remaining in a 
sample of R3PO•(HOO)2CR'R", a known mass of the adduct was used as an oxidant for 
PPh3, and the degree of its oxidation was observed through NMR spectroscopy. 
Oxidation of PPh3 was chosen for strategic reasons: PPh3 is solid and air-stable even in 
most solvents, and therefore it is easy to handle and any oxidation is not due to 
admission of air, but only to the oxidant. When dissolved in a solvent together with the 
above adduct, oxidation of PPh3 occurs immediately, with OPPh3 being the sole product. 
PPh3 and OPPh3 display two far apart, distinct peaks in the 
31
P NMR spectrum which are 
easy to identify and integrate.
49a-c
 
A series of 
31
P NMR spectra is collected following the addition of adduct to a 
weighed excess of PPh3. The samples are carefully prepared so that the concentration of 
each analyte exceeds 20 mM.
50
 The proton decoupler is turned off, because the Nuclear 
Overhauser Effect (NOE) can alter the peak intensities.
49d
 Three peaks occur in the 
spectrum, belonging to the carrier phosphine oxide of the spent adduct, OPPh3 and the 
remaining PPh3 (Figure 6.1). A capillary insert with neat ClPPh2 as the chemical shift 
standard is centered in the NMR tube (Figure 6.2).
6,50-51
 ClPPh2 is an ideal standard, as 
its peak occurs at 81.92 ppm, clear of the region of interest.
6,49a,52
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Figure 6.1. 
31
P NMR spectrum obtained following the partial oxidation of an excess of 
PPh3 with 5. 
 
 
 
Figure 6.2. Capillary insert with ClPPh2 centered inside a 5 mm NMR tube. 
 
 
By integrating the OPPh3 and PPh3 peaks, one can calculate what percentage of 
the original PPh3 has been oxidized. The number of moles of oxidized PPh3 corresponds 
to the number of moles of active peroxide groups that remain in the applied adduct after 
long term storage. Comparison of this number with the mole of peroxide that the 
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measured amount of pristine adduct contains, provides the degree of decomposition of 
the adduct. 
For an accurate determination of the integrals it is important that the signals are 
defined by a sufficient number of data points. A representative 
31
P NMR point spectrum 
of a sample after PPh3 oxidation (Figure 6.3) shows that the signals are defined by a 
sufficient number of data points, ensuring the quality of the integration. Since the 
intensity of a signal, and therewith the integral, when comparing the intensities of 
different signals, is calculated by adding the discrete height values of the data points, it is 
important that each peak incorporates a sufficient number of data points.
49d
 The digital 
resolution used typically for determining the integrals in this project is 0.56 Hz per point 
(65536 data points for a sweep width of 36764.71 Hz). Furthermore, it is important to 
allow for enough area around the signals when choosing the boundaries for their 
integration. Figure 6.3 shows representative signals with a sufficient number of data 
points and ample space around them. The integration extends 100 Hz in each direction 
from the center of PPh3 and OPPh3 peaks. It has been previously reported that 
integration should be performed over an area of 20-30 times the linewidth of the signal 
of interest for accurate analysis.
49a,49d
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Figure 6.3. Point display of the 
31
P NMR signals obtained after the partial oxidation of 
PPh3 with 5. 
 
 
This quantitative NMR method was furthermore tested against multiple criteria 
to validate its consistency. Specifically, it was tested whether the following factors 
influenced the integration of the signals: (1) the depth of insertion of the sample into the 
probehead, (2) the spectral range or sweep width, and (3) the applied relaxation delay. 
For checking factor (1), the sample is placed in three different positions within the 
probehead so that the bottom of the NMR tube would be 1.5 cm (A), 1.0 cm (B), and 0.5 
cm (C) below the region with the optimal RF (radio frequency) coil transmission and 
reception. Figure 6.4 indicates the bottom of the NMR tube in the sample gauge with a 
red line, and the area that the coil would stretch over in the probehead with a blue 
rectangle. The same sample was placed at the different positions into the probehead and 
31
P NMR spectra were measured with varying spectral windows and relaxation delays 
ranging from 1 to 40 seconds. 
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Figure 6.4. Three different positions of the 5 mm NMR tube inside the sample gauge, 
representing the probehead dimensions. For detailed description see text.  
 
 
Collecting NMR spectra of the sample at different positions within the probehead 
tests for equal RF homogeneity for the solubilized adduct, the initial PPh3 and the 
product OPPh3. Theoretically, if all components are homogeneously dispersed 
throughout the CDCl3 solution, changing the extent of the sample tube that is exposed to 
the region with optimal RF homogeneity should not change the ratio between PPh3 and 
OPPh3. However, the response of the various substances to the RF excitation could be 
different, thus leading to a deviating integral.  
When the spectral window is changed by moving it, the maximal intensity of the 
excitation pulse, which is in the center of the spectrum, is also moved. The closer the 
maximal intensity of the excitation pulse is to a signal of the sample, the more intense it 
will be in the spectrum (Figure 6.5).
49a
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Figure 6.5. 
31
P NMR spectra obtained following the oxidation of an excess of PPh3 with 
5. The change in the integrals with the change of the center of the excitation pulse is 
demonstrated.  
 
 
The different 
31
P nuclei in a sample require different relaxation times after a RF 
pulse is applied. Optimally, a subsequent pulse would not be applied until each nucleus 
is fully relaxed again. In case the next pulse is applied before the magnetization of one 
sort of nuclei is returned to the Boltzmann distribution equilibrium, it would reach 
eventually a steady state situation where the intensity of the signal does not show to its 
full extent. For maximum integration accuracy, all magnetizations of all species need to 
entirely return to equilibrium. Therefore, in order to obtain correct integral ratios 
between the PPh3 and OPPh3 peaks, it is paramount that the relaxation delay chosen is 
longer than the relaxation time that the involved nuclei require.
49a,49d,52
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Results and Discussion 
The decomposition temperatures of neat (HOO)2CR'R" adducts range from 70 to 
150 °C (Table C.1). Prior to recording the actual melting points, the adducts have been 
tested regarding their thermal stability by exposing them to gradually increasing 
temperatures in an oil bath to expedite decomposition. It should be noted that no 
explosive TATP or other explosive oligomers are formed during this process. The 
representative adducts 4 and 5 have also been tested by applying mechanical stress. No 
sudden release of oxygen occurred during forceful grinding or hammering of the pure 
powders. This may be due to the low weight% of active oxygen in the molecules, which 
is 7.9% for Cy3PO•(HOO)2CMe2 and 8.3% for Ph3PO•(HOO)2CMe2. The 
31
P NMR 
spectra before and after the grinding only show the starting materials. 
Thermogravimetric analyses (TGA) of 4 and 5 indicated that the (HOO)2CMe2 moiety, 
as a whole or in fragments, is lost upon heating (80-110 ºC), and this is followed by the 
loss of H2O2 molecules at 150 ºC, leaving the phosphine oxides behind (Figure 6.6). 
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Figure 6.6. Thermogravimetric analysis (TGA) of 5. 
 
 
Even in solution, the R3PO•(HOO)2CR'R" adducts are remarkably stable in the 
absence of a reducing agent. For example, heating a benzene solution of 4 to 90 °C and 
monitoring the solution with 
13
C NMR showed that three days were needed to 
decompose about 80% of 4. The main products remaining in solution were 
Ph3PO•H2O
6,17
 and acetone, besides traces of isopropanol, formic acid, and acetic acid 
(Figure A.79). 
Next, a QNMR method was developed to observe the shelf life of the 
representative adducts. The oxidation yields from the integrals of PPh3 and OPPh3 under 
varying factors, as described above, are summarized in Table 6.1. Comparing the results 
of A, B and C, the position of the NMR tube within the probe does not exhibit a 
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significant influence on the integral ratio. This was expected, since both the phosphine 
and the phosphine oxide are dispersed homogeneously in the NMR sample. On the other 
hand, changing the spectral ranges and therefore the point of irradiation with maximal 
intensity, shows a definite trend. As the excitation pulse frequency with maximal 
intensity moves closer, the OPPh3 peak intensity grows for all constellations A, B and C. 
Finally, the relaxation delay has to be longer than 35 seconds, in order for the phosphine 
oxide to relax completely.  
 
Table 6.1. Comparison of experimental and theoretical yields of OPPh3, expressed as %, 
following the oxidation of PPh3 with freshly synthesized 5. Experimental yields were 
calculated from the integral ratio of OPPh3 and PPh3 peaks in the 
31
P NMR spectra. 
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Ph3P oxidation was performed with representative adducts after they have been 
stored in polycrystalline form under different conditions. The adducts were exposed to 
the atmosphere at room temperature with and without light, and at -4 ºC and -20 ºC in 
the dark. At regular intervals aliquots were removed from the stored samples and the 
described Ph3P oxidation test was performed. 
31
P NMR spectra were recorded with a 
spectral range from 100 to -100 ppm and a relaxation delay of 35 seconds. In this way 
the oxidative power of the adducts was monitored for up to 100 days (Figure 6.7, Figure 
C.1-Figure C.3).  
 
 
Figure 6.7. Oxidative power of 5 after being stored at the indicated conditions. 100% 
equals to two moles of active oxygen per mole of 5.  
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At -20 and 4 °C the adducts retain most of their oxidative power over months. 
Exposure to light did not influence the decomposition, while the temperature played a 
dominant role. Furthermore, the exposed surface area of the materials made a difference. 
For example, large crystals (3×3×1 mm
3
) of 4-7, 9 and 10 retained 99% oxidative power 
after 100 days of being exposed to the ambient atmosphere and light at room 
temperature. Under the same conditions, the polycrystalline materials retain 60 to 70% 
of their oxidative power in the course of months. It is possible that the peroxides on the 
surface of the adduct are decomposing while the shielded molecules in the interior of the 
crystals remain unchanged.  
Decomposition may also occur in a stepwise manner, in which only one of the 
peroxide groups loses an oxygen atom, to initially form R3PO•(HOO)(HO)CR'R". 
Indeed, a single crystal X-ray structure obtained from large crystals of 
Cy3PO•(HOO)(HO)C(CH2)5 (16) (Figure 6.8)
53
 demonstrates that such a molecule is 
stable enough to assemble systematically and it might slow down decomposition.  
 
 
 
Figure 6.8. Large crystals (left) and single crystal X-ray structure (right) of 16.
53
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 Since this hydroperoxy(hydroxy)alkane adduct (16) is stable and melts without 
decomposition at 33 °C, it was possible to perform full characterization. In the IR 
spectrum two distinct stretching bands are observed, one each for the hydroxy O-H and 
the hydroperoxy O-H group (Figure B.19). In comparison to the di(hydroperoxy)-
cyclohexane adduct 10, the P=O bond is stronger, as evidenced from the frequency of 
P=O stretching band ν(P=O), which lies in between the values of neat Cy3PO and adduct 
10  (Table 6.2). The stronger P=O bond of 16 as compared to 10 can also be assumed 
due to the shorter bond length of the P=O group in the X-ray structure.  
 
Table 6.2. Comparison of IR and X-ray crystallographic data of Cy3PO, 16 and 10. 
 
Species 
ν(O-H) 
(cm
-1
) 
ν(P=O) 
(cm
-1
) 
Δν(P=O) 
(cm
-1
) 
P=O (Å ) 
Δ Bond 
length 
Cy3PO - 1157 - 1.490
42
 - 
16 
3323/ 
3246 
1144 13 1.509 +0.019 
10 3196 1123 24 1.512 +0.022 
 
 
The trend is continued in 
31
P NMR spectroscopy. Less electron density is 
removed from the P=O bond, and thus the phosphorus nucleus is more shielded than 10, 
and the signal for 16 appears more upfield shifted and closer to Cy3PO, with a Δδ value 
of approximately half of that of 10. The quaternary carbon on the (HOO)(HO)C(CH2)5 
moiety is also observed more upfield shifted compared to 10 (Table 6.3). Nonetheless, 
this monoperoxy adduct 16 is still capable of stoichiometrically oxidizing Ph3P to Ph3PO.   
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Table 6.3. Comparison of 
13
C and 
31
P NMR chemical shifts of Cy3PO, 16 and 10. 
 
Adduct 
δ(13C) Cq 
(ppm) 
δ (31P) P=O 
(ppm) 
δ (31P) neat 
R3PO (ppm) 
Δδ (ppm) 
16 102.65 53.34 
49.91 
3.43 
10 109.52 58.01 8.10 
 
 
Finally, the solubility of 16 was compared with those of the cyclic adducts 9-11 
(Figure 6.9). Adduct 16 shows slightly higher solubility than 9-11 in most solvents with 
the exception of chlorinated solvents, benzene, and THF.  
 
 
 
Figure 6.9. Solubility of the cyclic adducts 9-11 and “half-adduct” 16. 
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Conclusion 
 The decomposition of the adducts of the type R3PO•(HOO)2CR'R" was studied 
from multiple perspectives. The adducts were first exposed to thermal and mechanical 
stress, during which sudden release of energy was never observed, once again 
confirming the safety of these adducts.  
 Next, the decomposition rate of these adducts was studied under various storage 
conditions to test for their shelf life. In order to quantify the rate of decomposition, a 
quantitative NMR method was developed, involving the use of precise 
31
P NMR peak 
integration. Using this method, it was shown that the adducts decompose over time to 
about 70% when stored at room temperature in powder form. However, when the 
powder is stored at decreased temperatures of -4 °C, there is essentially no 
decomposition even after months. Moreover, when the adducts are stored as large single 
crystals, the decomposition is insignificant even at room temperature.  
 Since the adducts decompose much faster as powders than in the form of large 
crystals, it is hypothesized that the surface area plays a role in the decomposition of the 
peroxide groups. This decomposition can occur simultaneously at both peroxide 
positions, or it could take place in a stepwise manner, to form R3PO•(HOO)(HO)CR'R" 
as an intermediate. The latter assumption is supported by successful characterization of 
Cy3PO•(HOO)(HO)C(CH2)5 via single crystal X-ray crystallography, NMR and IR 
spectroscopy.  
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Experimental 
Cy3PO•(HOO)(HO)C(CH2)5 (16)  
300 mg of [Cy3PO•H2O2]2 (0.45 mmol) was dissolved in 10 mL of 
cyclohexanone (97 mmol) in a 20 mL vial. 1.5 mL aqueous H2O2 (15 mmol) was added 
to the vial, and the solution was stirred vigorously overnight, then left to crystallize via 
slow evaporation. Colorless rhombic crystals appeared after three days (327 mg, 0.76 
mmol, 84% yield). 
 
NMR (δ, CDCl3), 
31
P{
1
H} 53.34 (s); 
1
H 10.37 (s, 1H, OOH), 9.51 (s, 1H, OH), 1.95-
1.78 (m, 17H, PCHaxCHeqCHeq, OCCH) 1.74-1.68 (m, 3H, PCH(CH2)2CHeq), 1.67-1.60 
(m, 2H, CCH), 1.58-1.52 (m, 4H, CCH2CH2), 1.47-1.34 (m, 8H, PCHCHax, 
CCH2CH2CH2), 1.31-1.19 (m, 9H, PCHCH2CHaxCHax); 
13
C{
1
H} 102.65 (s, COO), 35.01 
(d, 
1
J(
31
P-
13
C) = 60.6 Hz, PC), 34.15 (s, CCH2), 26.80 (d, 
3
J(
31
P-
13
C) = 11.8 Hz, 
PCHCH2CH2), 26.11 (d, 
2
J(
31
P-
13
C) = 3.4 Hz, PCHCH2), 26.00 (d, 
4
J(
31
P-
13
C) = 1.7 Hz, 
PCH(CH2)2CH2), 25.40 (s, CCH2CH2CH2), 22.93 (s, CCH2CH2). IR: ν(PO) = 1143 cm
-1
. 
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CHAPTER VII  
APPLICATIONS IN OXIDATION REACTIONS

 
 
Introduction 
 The ultimate objective of this project is to apply the adducts of the type 
R3PO•(HOO)2CR'R" (R, R', R" = alkyl, aryl) as stoichiometric and soluble oxidizing 
agents in organic reactions. In the previous chapter, it was demonstrated that these 
adducts are capable of oxidizing PPh3 to OPPh3 selectively and stoichiometrically. The 
well-defined and reproducible composition of the adducts allows for stoichiometric 
application in reactions that are sensitive to overoxidation. This property of the adducts 
also makes them an attractive option in reactions such as sulfoxidations,
4b,4c,54
 where the 
sulfoxide (R2SO) is preferred to the sulfone (R2SO2).  
One particular example where selective oxidation to the sulfoxide is desired is in 
the neutralization of the chemical warfare agent mustard gas (bis(2-chloroethyl)sulfide, 
codename HD). Upon contact with an oxidant, the sulfide in HD is initially oxidized to 
the harmless HD-sulfoxide. However, overoxidation to the vesicant HD-sulfone occurs 
over time in the presence of excess oxidizing agent (Scheme 7.1).
55
  
 
 
                                                 

 Reproduced with permission from “Hydrogen Peroxide and Di(hydroperoxy)propane Adducts of 
Phosphine Oxides as Stoichiometric and Soluble Oxidizing Agents” Ahn, S. H.; Cluff, K. J.; 
Bhuvanesh, N.; Blümel, J. Angew. Chem. 2015, 127, 13539-13543. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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Scheme 7.1. Oxidation of HD to HD-sulfoxide and HD-sulfone in the presence of excess 
oxidant.  
 
 
Because the adducts R3PO•(HOO)2CR'R" (R, R', R" = alkyl, aryl) are stored in 
solid form, it is relatively easy to use them in reactions that require air- and moisture-
free conditions. Moreover, due to their high solubility in organic solvents, the oxidation 
reaction can occur in one phase, eliminating the need for phase transfer agents. The 
oxidation of PPh3 is relatively easy, as PPh3 is not air-sensitive in the solid state and in 
most solvents, and OPPh3 is the sole product with no occurrence of overoxidation. In the 
case of alkyl- and other phosphines which are sensitive to overoxidation and hydrolysis,
6
 
it is interesting to probe whether oxidation with the adducts of the type 
R3PO•(HOO)2CR'R" can proceed in a stoichiometric manner, and whether the reaction 
conditions would remain sufficiently anhydrous to prevent hydrolysis.
56
  
 For instance, 1,1,2,2-tetraphenyldiphosphine dioxide, Ph2P(O)-P(O)Ph2, is a 
species of interest because of its structural similarity to hypophosphoric acid, 
(RO)2P(O)-P(O)(OR)2, which exhibits anti-tumor activity.
56a
 The oxidation of 1,1,2,2-
tetraphenyldiphosphine, Ph2P-PPh2, to the dioxide is traditionally performed in dry 
solvents with oxygen gas, as the P-P bond is sensitive to hydrolysis. In the presence of 
moisture, the P-P bond is cleaved to produced a mixture of oxidized species, including 
Ph2P(O)H and Ph2P(O)OH.
57
 Therefore, this method of oxidation is inconvenient, also 
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because it involves the use of an oxygen gas cylinder. When exposed to dry air at merely 
atmospheric pressure, the oxidation is extremely slow and incomplete, with a mixture of 
diphosphine dioxide and diphosphine monoxide in the product mixture (Scheme 7.2, 
Figure A.92).
56a
  
 
 
Scheme 7.2. Oxidation of 1,1,2,2-tetraphenyldiphosphine in dry air. 
 
 
More recent approaches to the 1,1,2,2,-tetraphenyldiphosphine dioxide involve 1) 
the reaction between an electrophilic R2P(O)X (X = Cl, Br) and deprotonated R2POH, 2) 
an alkali metal reduction of R2P(O)X, or 3) the reaction of R2PCl with R2P(O)H and 
oxygen gas in anhydrous conditions.
56a
 However, all of these methods result in a mixture 
of products, including R2P(O)-P(O)R2 and R2P(O)-O-PR2. On the other hand, 
R3PO•(HOO)2CR'R" adducts are dry, solid materials that can simply be weighed in and 
administered in a stoichiometric manner. If successful, this provides a new and efficient 
way of selectively oxidizing 1,1,2,2,-tetraphenyldiphosphine to the diphosphine dioxide.  
Additionally, the potency of the adducts as oxidants in epoxidation reactions is 
studied. On one hand, the anhydrous properties of the adducts make them desirable, as 
the absence of water molecules should prevent the hydrolysis of the generated epoxide. 
However, the adducts are milder oxidants than aqueous H2O2, and thus may not be 
strong enough to activate all types of olefins.
8b,33
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Finally, the reactivity of the di(hydroperoxy)cycloalkane adducts 9-11 under 
Baeyer-Villiger reaction conditions is explored.
2,58
 Baeyer-Villiger oxidations are used 
to transform a cyclic ketone to its corresponding lactone. In the case of the adducts 9-11, 
a cyclic ketone is already used to generate the adduct molecule, which incorporates two 
moles of peroxides as potent oxidants. In this chapter, the transformation of the moiety 
(HOO)2C(CH2)n (n = 4-6) in the adducts to the corresponding lactone, with and without 
offering additional ketone, is studied in detail. 
 
Results and Discussion 
Sulfoxidation 
To study the application of the adducts R3PO•(HOO)2CR'R" as oxidants for 
reactands that are air-sensitive and prone to overoxidation, tetrahydrothiophene (THT) 
oxidation was selected.
4b,4c,54
 When 3 or 4 was combined with THT in a 1 : 2 molar ratio 
in benzene, it was selectively and quantitatively oxidized to tetramethylene sulfoxide at 
ambient temperatures within two hours (Scheme 7.3) 
 
 
Scheme 7.3. Stoichiometric oxidation of THT with R3PO•(HOO)2CR'R" (4-8, 12). 
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Generally, with adducts incorporating sterically more shielding substituents, the 
reaction times were increased (Table 7.1). However, the sulfoxide was still produced 
selectively, with the only other reaction products being the corresponding phosphine 
oxide carriers and the regenerated ketones. The resulting water molecule remains 
hydrogen bonded to the phosphine oxide group.
17
 This fast and clean reaction in one 
organic phase compares favorably to earlier studies which required biphasic mixtures 
and added catalysts.
4b,4c,54
 
  
Table 7.1. Selective and complete oxidation of THT to tetramethylene sulfoxide. 
 
 Reaction Time at Different Temperatures (h) 
Adduct 23 °C 50 °C 60 °C 
4 2  0.5  0.4 
5 2 0.5  0.4 
6 5 2  1  
7 8 3  1  
8 8 7  2 
12 6  1  0.5 
 
 
While the challenge regarding the oxidation of dialkyl sulfides lies in the 
selective oxidation to sulfoxides, oxidations of diaryl sulfides and thiophenes are 
intrinsically difficult due to low reactivity in the absence of a catalyst.
4a-c,4e,54,59
 
Following the successful selective oxidation of THT to tetramethylene sulfoxide, 
oxidation of diphenylsulfide was attempted using the adducts 4, 5, 7 and 8 (Scheme 7.4).  
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Scheme 7.4. Oxidation of Ph2S with R3PO•(HOO)2CR'R" (4, 5, 7, 8). 
 
 
Upon addition of the adduct and SPh2 in a 1 : 2 ratio in benzene at room 
temperature, no oxidation occurred even after a prolonged time period of 100 hours. 
When the reaction temperature was increased to 70 °C, conversion to the corresponding 
sulfoxide took place, with some overoxidation to the sulfone in two cases (Table 7.2). 
 
Table 7.2. Yields (%) of oxidized products Ph2SO and Ph2SO2 after reacting Ph2S with 
selected adducts R3PO•(HOO)2CR'R". 
 
Adduct Ph2SO  Ph2SO2 
4 60 11 
5 61 8 
7 40 0  
8 30 0 
 
 
 Adducts 4 and 5 exhibited the highest activities, oxidizing Ph2S in moderately 
high yields to Ph2SO without any catalyst, albeit extended reaction times of 100 h were 
required and some overoxidation to Ph2SO2 occurred. To increase the sulfoxide yield and 
minimize overoxidation to the sulfone, the oxidation reaction was repeated with adduct 7 
at room temperature, in the presence of catalytic amounts of silica and Br2, which have 
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been shown to be useful by another group previously.
60
 With the addition of silica and 
Br2, the sulfoxide yield remained 43% in acetonitrile and 47% in benzene, both after 100 
h of stirring (Table 7.3 entries 6 and 7). When silica was added without Br2, diphenyl-
sulfoxide and diphenylsulfone are produced in almost equal amounts (Entries 3 and 4). 
When Br2 is added without silica, the sulfoxide is obtained as the only product; however, 
the yield is decreased (Entry 5). Increasing the reaction temperature to 50 °C resulted in 
a high conversion of 86% after only one day of stirring. However, the major product was 
diphenylsulfone (53%), and the yield of diphenylsulfoxide was merely 33% (Entry 8). 
 
Table 7.3. Yields (%) of the oxidation products Ph2SO and Ph2SO2 after reaction of 
Ph2S with selected adducts R3PO•(HOO)2CR'R", with and without catalytic amounts of 
SiO2 and Br2.  
 
Entry Adduct SiO2 (g) Br2 Ph2SO Ph2SO2 
1 
7 
- 
- 
0 0 
2 - 40
[a]
 0 
3 0.5 25 25 
4 2.0 24 18 
5 - 
1 drop 
29 0 
6 0.5 43 0 
7 0.5 47
[b]
 0 
8 0.5 33
[c]
 53
[c]
 
9 5 0.5 49 0 
10 10 0.5 46 0 
[a] Reaction temperature 70 °C; [b] Reaction was performed in benzene; [c] Reaction temperature 50 °C. 
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 Assured that conducting the oxidation reaction at room temperature does not 
yield the sulfone, the sulfoxidation was attempted with adducts 5 and 10, using the same 
reaction conditions. In both cases, no overoxidation to the sulfone was observed, in 
contrast to previous results. The yields for the sulfoxide were similar to the ones 
obtained with adduct 7, with 49% for 5 and 46% for 10 (Table 7.3, entries 9 and 10).  
 Finally, the oxidation of thiophene was attempted using the adducts. Thiophene 
and adduct 7 were combined in a 2 : 1 ratio, and dissolved in acetonitrile (Scheme 7.5). 
After stirring for 4 days at room temperature, no oxidation occurred without silica and 
Br2 (Table 7.4, entry 1). With addition of catalytic amounts of silica and Br2, 41% 
conversion was observed, with thiophene oxide being the only product (Entry 2). No 
overoxidation was detected.  
 
 
Scheme 7.5. Oxidation of thiophene with the R3PO•(HOO)2CR'R" adduct 7. 
 
 
Table 7.4. Product yields (%) after oxidation of thiophene with 7. 
 
Entry SiO2 / Br2 Thiophene 1-oxide Thiophene 1,1-dioxide 
1 -  / - 0 0 
2 0.5 g / 1 drop 41 0 
 
 70 
 
Epoxidation 
Epoxidations of styrene and cyclohexene were attempted using the adducts 4-8 
(Scheme 7.6) in benzene.
8b,48d,61 
 
 
 
Scheme 7.6. Epoxidation attempts with R3PO•(HOO)2CR'R" adducts. 
 
 
In the absence of any catalyst, no reaction occurs, even at elevated temperatures 
(70 °C). This is plausible, as the adducts are milder oxidants than aqueous H2O2. When 
0.01 mol% of methyltrioxo rhenium (MTO) is added to the reaction mixture, 100% 
conversion is achieved, but the product is fully hydrolyzed to trans-1,2-
cyclohexanediol.
5c,61-62
 Further epoxidation attempts were discontinued due to time 
constraints. 
 
Phosphine oxidation  
 When Cy3PO•(HOO)2CMe2 (5) and Ph2P-PPh2 were added in a 1 : 1 ratio to dry 
benzene, the diphosphine dioxide was obtained as the main product (Scheme 7.7). While 
the resulting water adduct of the phosphine carrier, Cy3PO•H2O, is highly soluble in 
benzene, 1,1,2,2,-tetraphenyldiphosphine dioxide (17) is insoluble and precipitates out of 
the solution, allowing for easy separation from the reaction mixture (Figure A.93). In the 
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solid form, 17 is air-stable and can be stored for weeks without P-P bond cleavage due to 
hydrolysis or oxygen insertion.  
 
 
Scheme 7.7. Stoichiometric oxidation of 1,1,2,2-tetraphenyldiphosphine with 
Cy3PO•(HOO)2CMe2 (5) in benzene.  
  
  
17 was intended to serve as a diphosphine dioxide carrier for 
di(hydroperoxy)alkanes. The interest was to extend the known diphosphine dioxide 
adducts from those with two methylene groups between the P atoms (14, 15), via the one 
with one CH2 group (13) to an adduct with no carbon between the two PO groups. 
Therefore, an adduct synthesis with 17 as a new diphosphine dioxide carrier was 
attempted. However, when 17 was brought in contact with equal molar amounts of 
(HOO)2C(CH2)5 crystals, the P-P bond was immediately hydrolyzed to the phosphinic 
acid Ph2P(O)OH even in the absence of any solvent.  
 
Baeyer-Villiger oxidation 
 For each cycloalkane adduct  Cy3PO•(HOO)2C(CH2)n (n = 4-6) there is a cyclic 
ketone inherently present, arranged favorably with respect to its oxidation with two 
active peroxide groups attached to the quaternary carbon. In the presence of a catalytic 
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amount of H2SO4, these (HOO)2C(CH2)n moieties immediately form the corresponding 
free lactones in quantitative yields  (Scheme 7.8).  
 
 
Scheme 7.8. Formation of lactones from the cycloalkane adducts 
Cy3PO•(HOO)2C(CH2)n in the presence of trace amounts of acid. 
 
 
It is not yet clear whether the oxidation takes place while the 
di(hydroperoxy)cycloalkanes are still attached to the phosphine oxide carriers, or 
whether they are released from the phosphine oxides prior to the oxidation. Even though 
there are two peroxo groups per (HOO)2C(CH2)n moiety, no further oxidation of the 
lactones is observed, and the only other product remaining in the reaction mixture is 
Cy3PO•H2O (Table 7.5, entry 1). 
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Table 7.5. Baeyer-Villiger oxidation of substrate ketone and (HOO)2C(CH2)n moieties in 
the presence of a drop (< 1 mg) of H2SO4. 
 
   
 
For comparison, the Baeyer-Villiger oxidation was attempted with 
cyclopentanone and the hydrogen peroxide adduct [Cy3PO•H2O2]2 in a 2 : 1 molar ratio, 
again with only a trace amount of H2SO4. The corresponding δ-valerolactone is the only 
product, however, the yield is decreased to 55% (Table 7.5, entry 3). When the molar 
ratio of adduct to substrate is increased to 1 : 1, such that there are two active peroxide 
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groups per cyclopentanone, a mixture of δ-valerolactone and adduct 9 is obtained 
(Scheme 7.9, Table 7.5, entry 4). 
 
 
Scheme 7.9. Oxidation of cyclopentanone to δ-valerolactone and di(hydroperoxy)-
cyclopentane in the presence of 3 and trace amounts of acid.  
 
 
 In order to test whether the peroxo groups show selectivity with the attached 
cycloalkyl group over freshly added cyclic ketone, adduct 9 was reacted with 
cyclohexanone, and adduct 10 was reacted with cyclopentanone in a 1 : 1 molar ratio. In 
both cases, mixtures of δ-valerolactone and ε-caprolactone (Table 7.5, entries 5 and 6) 
are obtained, in approximately 1 : 1 molar ratio. Therefore, one can conclude that there 
is no preference for the oxidation of phosphine oxide-bound di(hydroperoxy)cyclo-
alkanes over the lactone formation from added free ketones. 
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Conclusion 
 The anhydrous and stoichiometric character of the di(hydroperoxy)alkane 
adducts R3PO•(HOO)2CR'R" (R, R', R" = alkyl, aryl) places them in a unique position in 
organic oxidation reactions. As demonstrated by the successful selective oxidation of 
tetrahydrothiophene and 1,1,2,2-tetraphenyldiphosphine, these adducts can be applied as 
oxidants in reactions that require air- and water-free conditions, as well as reactions with 
desired products that are sensitive to overoxidation.  
 The selectivity of these adducts stems from their exact stoichiometry and their 
mild oxidizing power, relative to aqueous H2O2. In the case of reluctant reactions such as 
diarylsulfide oxidation, a catalyst or initiator can be used in combination with the 
adducts to push the reaction forward. Overoxidation to R'R"SO2 does not occur under 
optimized reaction conditions, and the corresponding sulfoxide R'R"SO is obtained as 
the only product in good yields. In the presence of trace amounts of H2SO4, the 
di(hydroperoxy)cycloalkane moieties of 9-11 produce the corresponding lactones, 
leaving the phosphine oxide carriers behind.  
 While reactions such as epoxidations, which involve the activation of C=C bonds, 
are possible with the adducts R3PO•(HOO)2CR'R" in the presence of a catalyst like 
MTO, the adducts are most favorable for reactions that require mild oxidants, such as the 
oxidation of 1,1,2,2-tetraphenyldiphosphine. Because the oxidizing power of the adducts 
is mild, the P-P bond is not cleaved and the diphosphine dioxide 17 is obtained 
quantitatively. However, the scope of applications of these adducts is still being 
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expanded in every direction, including oxidations of substrates that contain sensitive 
functional groups.  
 
Experimental 
Tetrahydrothiophene (THT) oxidation 
 46 mg (0.1 mmol) of Cy3PO•(HOO)2C(CH2)4 (9) and 9 mg (0.1 mmol) of THT 
are weighed into a 20 mL vial inside a glove box and dissolved in 0.6 mL of C6D6. The 
vial is capped, and the contents are stirred. Every 10 minutes, an aliquot is transferred to 
an NMR tube, and the product identity and yield are determined by 
1
H and 
13
C NMR 
analyses. 
 
Tetrahydrothiophene NMR (δ, C6D6), 
1
H 2.55-2.42 (m, 4H, SCH2), 1.48-1.36 (m, 4H, 
SCH2CH2); 
13
C 31.37 (s, SC), 30.85 (s, SCH2C).
63
 
Tetramethylene sulfoxide NMR (δ, C6D6), 
1
H 2.89-2.74 (m, 4H, SCH2), 2.47-2.04 (m, 
4H, SCH2CH2); 
13
C 53.98 (s, SC), 25.02 (s, SCH2C).
64
 
 
SPh2 oxidation 
 In a representative reaction, 84 mg (0.2 mmol) of 7 and 78 mg (0.4 mmol) of 
Ph2S are weighed into a 20 mL vial. The mixture is then dissolved in 3 mL of distilled 
acetonitrile. Finally, 0.5 g of dry SiO2 and 1 drop (less than 1 mg) of Br2 are added to the 
vial, and the contents is stirred for 4 days. The reaction progress is monitored every 12 
hours via 
1
H and 
13
C NMR spectroscopy.  
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Ph2S NMR (δ, C6D6), 
1
H 7.47-7.26 (m, 10H); 
13
C 135.83 (s, Ci), 131.00 (s, Co), 129.11 
(s, Cm), 126.94 (s, Cp).
63
 
Ph2SO NMR (δ, C6D6), 
1
H 7.71-7.63 (m, 4H, Ho), 7.50-7.46 (m, 2H, Hp), 7.45-7.41 (m, 
4H, Hm); 
13
C 145.76 (s, Ci), 130.96 (s, Cp), 129.25 (s, Cm), 124.67 (s, Co).
64
 
Ph2SO2 NMR (δ, C6D6), 
1
H 7.95-7.91 (m, 4H, Ho), 7.55-7.53 (m, 2H, Hm), 7.52-7.49 (m, 
4H, Hp); 
13
C 141.53 (s, Ci), 133.21 (s, Cp), 129.27 (s, Cm), 127.54 (s, Co).
64
 
 
Thiophene oxidation 
84 mg (0.2 mmol) of 7 and 34 mg (0.4 mmol) of C4H4S  are weighed into a 20 
mL vial. The mixture is then dissolved in 3 mL of distilled acetonitrile. Finally, 0.5 g of 
dry SiO2 and 1 drop (less than 1 mg) of Br2 are added to the vial, and the contents is 
stirred for 4 days. The reaction progress is monitored every 12 hours via 
1
H and 
13
C 
NMR spectroscopy. 
 
Thiophene NMR (δ, C6D6), 
1
H 7.34-7.30 (m, 2H, SCH), 7.09-7.06 (m, 2H, SCHCH); 
13
C 
126.82 (s, SCC), 125.08 (s, SC).
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Thiophene-1-oxide NMR (δ, C6D6), 
1
H 7.34-7.30 (m, 2H, SCH), 7.09-7.06 (m, 2H, 
SCHCH); 
13
C 140.93 (s, SC), 126.48 (s, SCC).
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Baeyer-Villiger oxidation 
23 mg (0.05 mmol) of Cy3PO•(HOO)2C(CH2)4 is dissolved in 3 mL of benzene 
in a 20 mL vial, and a drop of H2SO4 (98 wt%) is added. The contents of the vial is 
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stirred for 20 min, and subsequently an NMR sample is prepared for 
1
H and 
13
C NMR 
analyses. δ-Valerolactone is produced in 100% yield, with respect to the 
di(hydroperoxy)cyclopentane moiety.  
In a new vial, 92 mg (0.2 mmol) of Cy3PO•(HOO)2C(CH2)4 (9) and 17 mg (0.2 
mmol) of cyclopentanone are dissolved in CDCl3 (1.0 mL). 1 drop of H2SO4 (98 wt%) is 
added, and the contents is stirred for 20 min. Both (HOO)2C(CH2)4 and cyclopentanone 
are oxidized to δ-valerolactone (58% yield according to 13C NMR). 
In another 20 mL vial, [Cy3PO•H2O2]2 (33 mg, 0.05 mmol) is reacted with 10 mg 
(0.12 mmol) of cyclopentanone and one drop of H2SO4 (98 wt%) in 1.0 mL of CDCl3. 
After stirring for 20 min, δ-valerolactone is produced in 55% yield with respect to the 
(HOO)2C(CH2)4 moiety, according to 
1
H NMR spectroscopy.  
When [Cy3PO•H2O2]2 (3) (66 mg, 0.11 mmol) is reacted with 10 mg (0.12 mmol) 
of cyclopentanone and H2SO4 (98 wt%), 100% conversion occurs, but the product is a 
mixture of δ-valerolactone and adduct 9.  
When 9 (46 mg, 0.1 mmol) is reacted with 10 mg (0.1 mmol) of cyclohexanone 
and one drop of H2SO4 (98 wt%) in 1.0 mL of CDCl3, a mixture of δ-valerolactone (21% 
yield) and ε-caprolactone (23% yield) are produced. Reacting adduct 10 with 
cyclopentanone in a 1 : 1 ratio results in a mixture of δ-valerolactone (24% yield) and ε-
caprolactone (22% yield) as well (Scheme 7.10).  
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Scheme 7.10. δ-Valerolactone (left) and ε-caprolactone (right), numbered for the 
purpose of NMR signal assignment.  
 
 
δ-Valerolactone NMR (δ, CDCl3), 
1
H 4.35-4.31 (m, 2H, H5), 2.58-2.51 (m, 2H, H2), 
2.15-1.63 (m, 4H, H3, H4); 
13
C 172.01 (s, C1), 69.45 (s, C5), 29.53 (s, C2), 21.96 (s, 
C4), 18.68 (s, C3).
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ε-Caprolactone NMR (δ, CDCl3), 
1
H 4.24-4.20 (m, 2H), 2.65-2.61 (m, 2H), 1.88-1.82 
(m, 2H), 1.79-1.70 (m, 4H); 
13
C 176.22 (s, C1), 69.30 (s, C6), 34.57 (s, C2), 29.34 (s, 
C4), 28.93 (s, C5), 22.99 (s, C3).
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Styrene oxidation 
In a representative styrene epoxidation attempt, 44 mg (0.1 mmol) of 
Cy3PO•(HOO)2CMeEt (7) and 23 mg of styrene (0.2 mmol) are combined in a 25 mL 
Schlenk flask and flushed with N2 gas. The mixture is dissolved in 3 mL of benzene and 
stirred overnight at each of following temperatures: room temperature, 40 ºC, 50 ºC, 60 
ºC, and 70 ºC. The reaction is monitored with 
1
H and 
13
C NMR spectroscopy. No 
conversion of styrene is observed.  
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440 mg (1 mmol) of Cy3PO•(HOO)2CMeEt (7), 230 mg (2 mmol) of styrene and 
5 mg (0.02 mmol, 1 mol%) of CH3ReO3 (MTO) are placed in a 100 mL Schlenk flask, 
flushed with N2 gas and dissolved in 40 mL of benzene. The reaction mixture is stirred 
for 2 h at room temperature. 
1
H and 
13
C NMR spectra show the hydrolyzed 
phenylethane-1,2-diol as the only product.
68
 
 
Phenylethane-1,2-diol NMR (δ, CDCl3), 
1
H 7.35-7.21 (m, 5H, aryl-H), 4.74-4.71 (m,  
1H, PhCH), 3.69-3.57 (m, 2H, CH2OH), 3.08 (s, 2H, OH); 
13
C 140.55 (s, Ci), 128.42 (s, 
Cm), 127.78 (s, Cp), 126.09 (s, Co), 74.71 (PhC), 67.95 (CH2).
68
 
 
Ph2P-PPh2 oxidation 
1,1,2,2-Tetraphenyldiphosphane Ph2P-PPh2 is synthesized according to a 
literature method in 83% isolated yield.
69
 The 
1
H and 
13
C NMR peaks are determined 
using 
13
C,
1
H HMBC and COSY NMR spectra. The 
1
H and 
31
P NMR signals agree with 
literature values,
69
 and 
13
C NMR signals agree with trends found in the literature for 
arylphosphines.
6
 
NMR (δ, CDCl3), 
31
P -14.84 (s); 
1
H 7.39-7.35 (m, 8H, Ho), 7.26 (m, 4H, Hp), 7.20 (m, 
8H, Hm);
69
 
13
C 135.64 (virtual t, J(
31
P-
13
C) = 5.1 Hz, Ci) 134.30 (virtual t,
 
J(
31
P-
13
C) = 
12.6 Hz, Co), 128.66 (s,
 
Cp), 128.20 (virtual t, J(
31
P-
13
C) = 3.3 Hz, Cm). mp 96-98 °C. 
 
41 mg (0.11 mmol) of Ph2P-PPh2 and 47 mg (0.12 mmol) of 
Cy3PO•(HOO)2CMe2 are filled into an NMR tube flushed with N2 gas. When 0.4 mL of 
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C6D6 is added to the tube, it heats up immediately. Initially, the sample forms a cloudy 
solution. However, after a few minutes, Ph2P(O)-P(O)Ph2 precipitates as a white powder 
and settles at the bottom of the tube. The water adduct of the phosphine oxide carrier, 
Cy3PO•H2O, remains dissolved in C6D6, allowing for easy separation of the product 
Ph2P(O)-P(O)Ph2 via filtration. The solid Ph2P(O)-P(O)Ph2 is redissolved in 0.5 mL of 
CDCl3 and characterized with 
1
H, 
13
C and 
31
P NMR spectroscopy. The 
1
H and 
31
P NMR 
signals agree with literature values.
56a
 
13
C NMR signal assignment is reported for the 
first time in this dissertation.  
 
NMR (δ, CDCl3), 
31
P 23.71 (s); 
1
H 7.93 (dd, 
3
J(
31
P-
1
H) = 12.5 Hz, 
3
J(
1
H-
1
H) = 7.6 Hz, 
8H, Ho), 7.49 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 4H, Hp), 7.40 (t, 
3
J(
1
H-
1
H) = 7.6 Hz, 8H, Hm);
56a
 
13
C 132.43 (s, Ci) 131.80 (virtual t,
 
J(
31
P-
13
C) = 5.1 Hz, Co), 128.57 (virtual t, J(
31
P-
13
C) 
= 6.1 Hz, Cm), 128.32 (s,
 
Cp). 
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CHAPTER VIII 
MISCELLANEOUS RESULTS 
 
Introduction 
 Di(hydroperoxy)alkane adducts of phosphine oxides are easily synthesized and 
crystallized. The synthetic method was tested across a wide scope of phosphine oxides 
and ketones, and all starting materials have successfully produced the expected adducts. 
However, in one case a completely different species was obtained as product.  
In the absence of phosphine oxide, butanone is known to react with H2O2 to form 
2,2'-peroxydi(butane-2-peroxol), [HOOCMeEtO-]2, commonly referred to as 
methylethylketone peroxide (MEKPO).
70
 This substance is used in the polymer industry 
as a catalyst for acrylic resins or as curing agent for unsaturated polyester resins, and is 
produced by addition of aqueous H2O2 to 2-butanone in the presence of acid.
71,72
 
Regarding the previously described adducts of phosphine oxides, the strong hydrogen 
bond between the phosphine oxide and the 2,2-di(hydroxy)butane prevents the formation 
of MEKPO. However, in one case the MEKPO came into existence nonetheless, forming 
a network of hydrogen bonds with the phosphine oxides in the reaction mixture.  
Following a similar line of thought, it was hypothesized that diketones which 
normally undergo cyclization upon reaction with H2O2,
73
 could instead form 
di(hydroperoxy) moieties from each carbonyl group and become attached to diphosphine 
dioxides with a fitting distance between the PO groups, through hydrogen bonding. 
Surprisingly, it turned out that bidentate phosphine oxides can act as bystander 
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molecules, and from a series of experiments different forms of cyclized products were 
isolated and crystallized. In this chapter, the synthesis and characterization of these 
serendipitously found molecules, which do not align with the adducts 4-15, are described 
in detail.   
 
Results and Discussion 
 When acetone and 3-pentanone were combined with 
bis(diphenylphosphino)ethane dioxide (dppe dioxide), the adducts 14 and 15 were 
formed, respectively. However, when butanone was combined with this diphosphine 
dioxide and an excess of aqueous H2O2, the crystallized product obtained in 83% yield, 
poly(2,2’-peroxydi(butane-2-peroxol)-bis(diphenylphosphino)ethane dioxide) (18), 
shows a polymeric structure, consisting of dppe dioxide and MEKPO (Figure 8.1).
74
 The 
two phosphine oxide groups point in opposite directions and form hydrogen bonds with 
the hydroperoxy functionalities of different MEKPO molecules.  
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Figure 8.1. Single crystal X-ray structure of material 18.
74
 
 
 
 Perhaps the ideal packing of the phenyl groups in dppe dioxide promotes the 
formation of MEKPO as opposed to the di(hydroperoxy)butane moieties found in the 
adducts 6 and 7. Another factor favoring the structure of the material is the similar 
lengths of the P-C-C-P and C-O-O-C units, which allow for their parallel arrangement 
and strainless stacking in the crystal. The slight difference in the lengths is made up for 
by the hydrogen bonds. It is yet to be seen whether a similar polymer forms with the 
cyclohexyl analog of dppe dioxide, [Cy2P(O)CH2]2. 
 Since dppe dioxide is able to form multiple hydrogen bonds to 
di(hydroperoxy)alkanes, the next step in synthesis involved expanding the scope of 
ketones to diketones. It was interesting to see whether both carbonyl groups would 
undergo nucleophilic attack to each form the di(hydroperoxy)alkane moiety, and finally 
bind to phosphine oxides, as shown for one example in Scheme 8.1.  
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 To test this idea, dppm dioxide and dppp dioxide were chosen as the phosphine 
oxides, and acetylacetone was selected as the diketone. While the two P=O groups in 
dppe dioxide point away from each other in the structures we have obtained so far, the 
P=O groups in dppm dioxide and dppp dioxide point in the same direction, and are in 
close enough proximity to form hydrogen bonds, should the acetylacetone successfully 
form di(hydroperoxy)alkane moieties at both carbonyl positions (Scheme 8.1).  
 
 
Scheme 8.1. Attempted synthesis of the shown desired adduct. 
 
 
 Unfortunately, the two carbonyl groups in acetylacetone are so close to each 
other that as soon as one carbonyl group undergoes a nucleophilic attack by hydrogen 
peroxide, the second carbonyl group is attacked by the resulting hydroperoxide, forming 
a five-membered ring (Scheme 8.2).
46,75
  Unlike the cases of previous adducts, where the 
phosphine oxides favorably formed hydrogen bonds with the di(hydroperoxy)alkane 
moieties and thereby prohibited the cyclic condensation of acetone peroxide or butanone 
peroxide, the presence of dppm dioxide or dppp dioxide does not prevent the formation 
of the cycloperoxide according to the pathway diplayed in Scheme 8.2 below.  
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Scheme 8.2. Synthesis of cyclic di(hydroxy)peroxide. 
 
 
Depending on the concentration of the aqueous H2O2 in the reaction mixture, the 
3,5-dimethyl-1,2-dioxolane-3,5-diol (19)
76
 or the 3,5-dihydroperoxy-3,5-dimethyl-1,2-
dioxolane (20)
77
 are obtained. An orderly network of hydrogen bonds is formed for both 
19 and 20, and both crystallize easily, without any interaction with the phosphine oxide 
in solution (Figure 8.2, Figure 8.3). As seen from the X-ray structures, both compounds 
form the trans isomer. The same compounds could also be synthesized just as easily in 
the absence of chelating phosphine oxides, but with acid catalysis.
46
  
 
 
Figure 8.2. Single crystal X-ray structure of a single molecule of 19 (left) and 19 in the 
unit cell (right).
76
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Figure 8.3. Single crystal X-ray structure of a single molecule of 20 (left) and 20 in the 
unit cell (right).
77
 
 
 These diol and dioxolane compounds have been known for some time,
46,73,75
 but 
the X-ray crystal structures have not been reported yet. Previous reports state that 
reactions of diketones with aqueous H2O2 at room temperature form inseparable 
mixtures of the di(hydroxy)peroxide (19), di(hydroperoxy)peroxide (20), and 
hydroperoxyperoxides (Figure 8.4).
46,73,75
 Contrary to this, in our hands 19 and 20 were 
both obtained as isolated products in high yields, without the need for further 
purification.  
 
 
Figure 8.4. Potential products from reaction of acetylacetone with aq. H2O2.  
 88 
 
Conclusion 
 Unlike the cases of the adducts 6 and 7, reacting H2O2 with butanone in the 
presence of dppe dioxide gives the methylethylketone peroxide molecule (MEKPO). The 
hydroperoxides at either end of the MEKPO molecule form hydrogen bonds with 
phosphine oxide groups of different dppe dioxide molecules, thereby generating the 
polymeric adduct 18. This adduct is stable and it has been obtained in the form of large 
single crystals.  
 The presence of dppm dioxide does not prohibit the cyclization of the diketone 
when being treated with aqueous H2O2. Acetylacetone undergoes nucleophilic attack by 
aqueous H2O2 to form the trans-cycloperoxides 19 and 20. These two species were 
successfully characterized by single crystal X-ray crystallography, and the structures 
show intricate networks of intermolecular hydrogen bonds.  
 
Experimental 
Poly(2,2’-peroxydi(butane-2-peroxol)-bis(diphenylphosphino)ethane dioxide) (18) 
In a round bottom flask, dppe dioxide (103 mg, 0.24 mmol) was dissolved in 10 
mL of toluene. 10 mL (112 mmol) of butanone and 0.1 mL (1 mmol) of aqueous H2O2 
was added, and the solution was stirred overnight. The solution was concentrated in 
vacuum to 5 mL, then the mixture was left so that the product could crystallize. Adduct 
19 was obtained in the form of large, colorless, rectangular crystals (126 mg, 0.20 mmol, 
83% yield). 
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NMR (δ, CDCl3), 
31
P{
1
H} 36.91 (s); 
1
H 11.27 (br. s, 2H, OOH), 7.76-7.71 (m, 8H, Ho), 
7.56-7.51 (m, 4H, Hp), 7.49-7.45 (m, 8H, Hm), 2.59 (d, 
2
J(
31
P-
1
H) = 2.7 Hz, 4H, PCH2), 
1.81 (q, 
3
J(
1
H-
1
H) = 7.6 Hz, 4H, CH2CH3), 1.44 (s, 6H, CCH3), 1.03 (t, 
3
J(
1
H-
1
H) = 7.6 
Hz, 6H, CH2CH3); 
13
C{
1
H} 132.49 (s, Cp), 130.73 (d, 
1
J(
31
P-
13
C) = 102.8 Hz, Ci), 130.70 
(virtual triplet, J(
31
P-
13
C) = 4.7 Hz, Co), 129.08 (virtual triplet, J(
31
P-
13
C) = 6.1 Hz, Cm), 
111.73 (s, CCH3), 26.15 (s, CH2CH3), 21.31 (t, 
3
J(
31
P-
13
C) = 33.0 Hz, PCH2), 17.49 (s, 
CCH3), 8.39 (s, CH2CH3). IR: ν(PO) = 1437.0 cm
-1
. 
 
3,5-Dimethyl-1,2-dioxolane-3,5-diol (19) 
Dppp (1.001 g, 2.43 mmol) is dissolved in 60 mL of CH2Cl2. Aqueous H2O2 (5.0 
mL, 0.05 mol) is added, and the solution is stirred for 1 h. The organic layer is collected 
using a separation funnel, and the solvent is removed in vacuo. The resulting white 
residue is dissolved in 2.5 mL (24.3 mmol) of acetylacetone, followed by the addition of 
excess aqueous H2O2 (0.1 mL, 1.0 mmol). The solution is stirred for 3 days, then the 
mixture is allowed to stand for crystallization. The unintentional product 19 is obtained 
in the form of white, crystalline needles (94 mg, 0.71 mmol, 71% yield with respect to 
amount of H2O2 added into the acetylacetone), while an oily liquid remains. 
The procedure is repeated without phosphine oxide. 100 mg (1 mmol) of 
acetylacetone is weighed into a vial, followed by 0.15 mL (1.5 mmol) of H2O2. The 
solution is stirred overnight, and excess water is removed with vacuum. Benzene (1.0 
mL) is used to precipitate the product, which is filtered and dried in vacuo. (83 mg, 0.62 
mmol, 62% yield). 
1
H and 
13
C NMR data match the literature values.
46
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NMR (δ, CDCl3), 
1
H 2.74 (s, 2H, CH2), 1.63 (s, 6H, CH3); 
13
C 105.50 (s, OC), 55.23 
(CH2), 22.59 (CH3). mp (decomp.) 82 °C. 
 
3,5-Dihydroperoxy-3,5-dimethyl-1,2-dioxolane (20) 
100 mg (1 mmol) of acetylacetone is weighed into a vial and combined with 1.0 
mL (10 mmol) of aqueous H2O2. The solution is stirred overnight, and the excess of 
water is removed with vacuum. Benzene (1.0 mL) is used to precipitate the product (113 
mg, 0.68 mmol, 68% yield). 
1
H and 
13
C NMR data match the literature values.
46
 
 
NMR (δ, CDCl3), 
1
H 8.54 (s, 2H, OH), 2.74 (s, 2H, CH2), 1.63 (s, 6H, CH3); 
13
C 112.99 
(s, OC), 51.11 (CH2), 17.52 (CH3). mp (decomp.) 98 °C.  
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CHAPTER IX 
SUMMARY 
 
Hydrogen peroxide and di(hydroperoxy)alkane adducts of phosphine oxides are 
presented as solid, safe, stoichiometric and soluble oxidizing agents. Structural motifs of 
H2O2 adducts with different R3PO : H2O2 ratios are highlighted by single crystal 
analyses, and the physical properties of all adducts are described in detail.  
Di(hydroperoxy)alkane adducts of phosphine oxides are successfully synthesized 
at room temperature in high yields, without the use of acid or metal catalysts. 
Phosphines, phosphine oxides, and H2O or H2O2 adducts of phosphine oxides can be 
used as the starting materials. While high solubility of these starting materials in CH2Cl2 
renders it an attractive solvent, the corresponding ketone can just as well be used as the 
solvent. This one-pot, general synthetic method has been applied to a wide variety of 
phosphine oxides and ketones, and the resulting adducts can be safely and easily isolated 
in the form of large crystals. The general synthetic approach also allows for easy 
recycling of the phosphine oxide carriers. The adducts can be regenerated by simply 
stirring the phosphine oxides in a solution of excess H2O2 and ketone.  
All adducts have been fully characterized, using mostly the methods multinuclear 
NMR and IR spectroscopy, X-ray crystallography and melting point analyses. 
13
C NMR 
spectroscopy is especially valuable as a diagnostic tool, as the quaternary carbon on the 
(HOO)2CR'R" moiety displays a unique signal at 108-120 ppm, and the product can be 
identified prior to its isolation. X-Ray crystallography and IR spectroscopy show 
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significant elongation and weakening of the P=O bond as a result of  hydrogen bonding 
to the (HOO)2CR'R" moiety. 
 IR spectroscopy also confirms the absence of water molecules in the adducts. 
Moreover, the adducts are insoluble in H2O, but they show high solubility in many 
common organic solvents. Thus, when used as oxidizing agents, the oxidation reaction 
can be performed in a single organic phase. 
Because these adducts have a well-defined molecular structure, the exact number 
of active oxygen atoms can be easily calculated. The anhydrous and stoichiometric 
character of the adducts of the type R3PO•(HOO)2CR'R" allows for their application as 
oxidants in reactions that require air- and water-free conditions, as well as reactions that 
are sensitive to overoxidation. Indeed, dialkyl sulfides were selectively oxidized to 
sulfoxides, and 1,1,2,2-tetraphenyldiphosphine was transformed quantitatively into the 
corresponding dioxide without hydrolysis of the P-P bond or oxygen insertion.  
  In the case of reluctant educts such as diarylsulfides, a catalyst or initiator can be 
used in combination with the adducts to push the reaction forward. Overoxidation to the 
sulfones R'R"SO2 can be prevented by careful control of the reaction conditions. In the 
presence of acid, but no other substrate, the di(hydroperoxy)cycloalkane moieties are 
transformed into the corresponding free lactones and the phosphine oxide carriers.  
 Decomposition of the adducts R3PO•(HOO)2CR'R" under thermal and 
mechanical stress was studied in more detail. Upon heating, hammering and grinding, no 
sudden release of oxygen or other sign of violent decomposition was observed, 
confirming the safety of these adducts. Furthermore, the long term stability and shelf life 
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of the adducts was studied by storing them under various conditions. A quantitative 
NMR method was developed to study the rate of decomposition. The oxidation capacity 
of the stored adducts was monitored by the oxidation of Ph3P, and the amount of 
oxidized Ph3P was calculated via 
31
P NMR peak integration. This number was compared 
to the mass of adduct used for the oxidation to quantify the number of active peroxide 
groups remaining in the adduct. Using this method, it has been shown that the adducts 
decompose to about 70% of their original oxidative power when stored as powders at 
room temperature for several months. However, when the powders are stored at a lower 
temperature of -4 ºC, there is essentially no decomposition even after months. Moreover, 
when the adducts are stored as large single crystals, decomposition is insignificant even 
at room temperature.  
 In one particular case, adduct synthesis with 2-butanone in the presence of a 
stoichiometric amount of dppe dioxide resulted in the condensation to methylethylketone 
peroxide (MEKPO), which then formed hydrogen bonds to two molecules of dppe 
dioxide. The resulting adduct displayed a polymeric structure, as opposed to the discrete 
molecular structures observed for R3PO•(HOO)2CMeEt (R = Cy, Ph). It is hypothesized 
that the sterics of dppe dioxide is favorable for packing with MEKPO, and thus unlike 
the previous adducts, condensation of 2,2-di(hydroperoxy)butane to MEKPO is not 
prohibited by the presence of phosphine oxide bonds.  
 The presence of phosphine oxide also does not interfere with cyclization of 
diketones with H2O2. Acetylacetone undergoes nucleophilic attack by aqueous H2O2 to 
form trans-cycloperoxides. Depending on the concentration of H2O2, either 3,5-
 94 
 
dimethyl-1,2-dioxolane-3,5-diol or 3,5-dihydroperoxy-3,5-dimethyl-1,2-dioxolane is 
isolated as the sole product. Both species form an intricate network of hydrogen bonds 
with neighboring molecules and crystallize easily. This might be the reason why no 
interactions with the offered diphosphine dioxides are observed.  
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APPENDIX A 
NMR SPECTRA 
 
 
 
Figure A.1. 
1
H NMR spectrum of 1 in CDCl3.  
 
 
 
 
Figure A.2. 
13
C{
1
H} NMR spectrum of 1 in CDCl3. 
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Figure A.3. 
31
P{
1
H} NMR spectrum of 1 in CDCl3. 
 
 
 
 
 
Figure A.4. 
1
H NMR spectrum of 1 in acetone-d6. 
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Figure A.5. 
13
C{
1
H} NMR spectrum of 1 in acetone-d6. 
 
 
 
 
 
Figure A.6. 
31
P{
1
H} NMR spectrum of 1 in acetone-d6. 
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Figure A.7. 
1
H NMR spectrum of 4 in CDCl3. 
 
 
 
 
 
Figure A.8. 
13
C{
1
H} NMR spectrum of 4 in CDCl3. 
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Figure A.9. Expansion of aryl region of 
13
C{
1
H} NMR spectrum of 4 in CDCl3. 
 
 
 
 
 
 
Figure A.10. 
31
P{
1
H} NMR spectrum of 4 in CDCl3. 
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Figure A.11. 
1
H NMR spectrum of 4 in acetone-d6. 
 
 
 
 
 
Figure A.12. 
13
C{
1
H} NMR spectrum of 4 in acetone-d6. 
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Figure A.13. 
13
C{
1
H} NMR spectrum of 4 in acetone-d6, aryl region expansion. 
 
 
 
 
 
Figure A.14. 
31
P{
1
H} NMR spectrum of 4 in acetone-d6. 
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Figure A.15. 
1
H NMR spectrum of 5 in CDCl3 (top), alkyl region expansion (bottom). 
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Figure A.16. 
13
C{
1
H} NMR spectrum of 5 in CDCl3. 
 
 
 
 
 
Figure A.17. 
13
C{
1
H} NMR spectrum of 5 in CDCl3, alkyl region expansion. 
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Figure A.18. 
13
C, 
1
H COSY NMR spectrum of 5 in CDCl3. 
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Figure A.19. 
31
P{
1
H} NMR spectrum of 5 in CDCl3. 
 
 
 
 
 
 
 
 
 
Figure A.20. 
1
H NMR spectrum of 5 in acetone-d6. 
 
 
 
 114 
 
 
Figure A.21. 
1
H NMR spectrum of 5 in acetone-d6, alkyl region expansion. 
 
 
 
 
 
 
Figure A.22. 
13
C{
1
H} NMR spectrum of 5 in acetone-d6. 
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Figure A.23. 
13
C{
1
H} NMR spectrum of 5 in acetone-d6, alkyl region expansion. 
 
 
 
 
 
Figure A.24. 
31
P{
1
H} NMR spectrum of 5 in acetone-d6. 
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Figure A.25. 
1
H NMR spectrum of 6 in CDCl3. 
 
 
 
 
Figure A.26. 
13
C{
1
H} NMR spectrum of 6 in CDCl3. 
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Figure A.27. 
31
P{
1
H} NMR spectrum of 6 in CDCl3. 
 
 
 
 
 
Figure A.28. 
1
H NMR spectrum of 6 in C6D6. 
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Figure A.29. 
13
C{
1
H} NMR spectrum of 6 in C6D6. 
 
 
 
 
 
Figure A.30. 
31
P{
1
H} NMR spectrum of 6 in C6D6. 
 
 119 
 
 
Figure A.31. 
1
H NMR spectrum of 7 in CDCl3 (top), alkyl region expansion (bottom). 
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Figure A.32. 
13
C{
1
H} NMR spectrum of 7 in CDCl3. 
 
 
 
 
 
Figure A.33. 
13
C{
1
H} NMR spectrum of 7 in CDCl3, alkyl region expansion. 
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Figure A.34. 
31
P{
1
H} NMR spectrum of 7 in CDCl3. 
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Figure A.35. 
1
H NMR spectrum of 8 in CDCl3. 
 
 
 
 
 
Figure A.36. 
1
H NMR spectrum of 8 in CDCl3, alkyl region expansion. 
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Figure A.37. 
13
C{
1
H} NMR spectrum of 8 in CDCl3. 
 
 
 
 
 
Figure A.38. 
13
C{
1
H} NMR spectrum of 8 in CDCl3, alkyl region expansion. 
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Figure A.39. 
31
P{
1
H} NMR spectrum of 8 in CDCl3. 
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Figure A.40. 
1
H NMR spectrum of 9 in CDCl3. 
 
 
 
 
 
Figure A.41. 
1
H NMR spectrum of 9 in CDCl3, alkyl region expansion. 
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Figure A.42. 
13
C{
1
H} NMR spectrum of 9 in CDCl3. 
 
 
 
 
 
Figure A.43. 
13
C{
1
H} NMR spectrum of 9 in CDCl3, alkyl region expansion. 
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Figure A.44. 
31
P{
1
H} NMR spectrum of 9 in CDCl3. 
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Figure A.45. 
1
H NMR spectrum of 10 in CDCl3. 
 
 
 
 
 
 
Figure A.46. 
1
H NMR spectrum of 10 in CDCl3, alkyl region expansion. 
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Figure A.47. 
13
C{
1
H} NMR spectrum of 10 in CDCl3. 
 
 
 
 
 
Figure A.48 
13
C{
1
H} NMR spectrum of 10 in CDCl3, alkyl region expansion. 
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Figure A.49. 
31
P{
1
H} NMR spectrum of 10 in CDCl3. 
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Figure A.50. 
1
H NMR spectrum of 11 in CDCl3. 
 
 
 
 
 
 
Figure A.51. 
1
H NMR spectrum of 11 in CDCl3, alkyl region expansion. 
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Figure A.52. 
13
C{
1
H} NMR spectrum of 11 in CDCl3. 
 
 
 
 
 
 
Figure A.53. 
13
C{
1
H} NMR spectrum of 11 in CDCl3, alkyl region expansion. 
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Figure A.54. 
31
P{
1
H} NMR spectrum of 11 in CDCl3. 
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Figure A.55. 
1
H NMR spectrum of 12 in CDCl3. 
 
 
 
 
 
Figure A.56. 
1
H NMR spectrum of 12 in CDCl3, alkyl region expansion. 
 135 
 
 
Figure A.57. 
13
C{
1
H} NMR spectrum of 12 in CDCl3. 
 
 
 
 
Figure A.58. 
13
C{
1
H} NMR spectrum of 12 in CDCl3, alkyl region expansion. 
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Figure A.59. 
31
P{
1
H} NMR spectrum of 12 in CDCl3. 
  
 137 
 
 
Figure A.60. 
1
H NMR spectrum of 13 in CDCl3.  
 
 
 
 
 
 
Figure A.61. 
1
H NMR spectrum of 13 in CDCl3, aryl region expansion. 
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Figure A.62. 
13
C{
1
H} NMR spectrum of 13 in CDCl3. 
 
 
 
 
Figure A.63. 
13
C{
1
H} NMR spectrum of 13 in CDCl3, aryl region expansion. 
 139 
 
 
Figure A.64. 
31
P{
1
H} NMR spectrum of 13 in CDCl3. 
 
 
 
 
 
 
Figure A.65. 
1
H NMR spectrum of 13 in acetone-d6. 
 140 
 
 
Figure A.66. 
1
H NMR spectrum of 13 in acetone-d6, aryl region expansion. 
 
 
 
 
 
 
Figure A.67. 
13
C{
1
H} NMR spectrum of 13 in acetone-d6. 
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Figure A.68. 
13
C{
1
H} NMR spectrum of 13 in acetone-d6, aryl region expansion. 
 
 
 
 
 
 
Figure A.69 
31
P{
1
H} NMR spectrum of 13 in acetone-d6. 
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Figure A.70. 
1
H NMR spectrum of 14 in CDCl3. 
 
 
 
 
Figure A.71. 
13
C{
1
H} NMR spectrum of 14 in CDCl3. 
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Figure A.72. 
13
C{
1
H} NMR spectrum of 14 in CDCl3, aryl region expansion. 
 
 
 
 
Figure A.73. 
31
P{
1
H} NMR spectrum of 14 in CDCl3. 
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Figure A.74. 
1
H NMR spectrum of 15 in CDCl3.  
 
 
 
 
 
Figure A.75. 
1
H NMR spectrum of 15 in CDCl3, aryl region expansion. 
 145 
 
 
Figure A.76. 
13
C{
1
H} NMR spectrum of 15 in CDCl3. 
 
 
 
 
Figure A.77. 
13
C{
1
H} NMR spectrum of 15 in CDCl3, aryl region expansion. 
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Figure A.78. 
31
P{
1
H} NMR spectrum of 15 in CDCl3. 
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Figure A.79. 
13
C NMR spectrum of 4 in benzene after heating at 90 °C for 3 days.  
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Figure A.80. 
1
H NMR spectrum of 16 in CDCl3. 
 
 
 
 
 
Figure A.81. 
1
H NMR spectrum of 16 in CDCl3, alkyl region expansion. 
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Figure A.82. 
13
C{
1
H} NMR spectrum of 16 in CDCl3. 
 
 
 
 
 
Figure A.83. 
13
C{
1
H} NMR spectrum of 16 in CDCl3, alkyl region expansion. 
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Figure A.84. 
31
P{
1
H} NMR spectrum of 16 in CDCl3. 
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Figure A.85. 
1
H NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in CDCl3. 
 
 
 
 
 
Figure A.86. 
1
H NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in CDCl3, aryl region 
expansion. 
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Figure A.87. 
13
C{
1
H} NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in CDCl3. 
 
 
 
 
 
 
Figure A.88. 
13
C{
1
H} NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in CDCl3, aryl 
region expansion. 
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Figure A.89. 
13
C, 
1
H HSQC NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in CDCl3. 
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Figure A.90. 
13
C, 
1
H HMBC NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in 
CDCl3.  
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Figure A.91. 
31
P{
1
H}NMR spectrum of 1,1,2,2-tetraphenyldiphosphine in CDCl3. 
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Figure A.92. Oxidation of 1,1,2,2-tetraphenyldiphosphine in air over a period of 5 days.  
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Figure A.93. Stoichiometric oxidation of 1,1,2,2-tetraphenyldiphosphine with 5 as 
oxidant; starting phosphine in C6D6 (bottom), product 1,1,2,2-tetraphenyldiphosphine 
dioxide and consumed adduct in C6D6 (middle), and 1,1,2,2-tetraphenyldiphosphine 
dioxide isolated via simple filtration and dissolved in CDCl3 (top). 
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Figure A.94. 
1
H NMR spectrum of 1,1,2,2-tetraphenyldiphosphine dioxide (17) in 
CDCl3. 
 
 
 
 
 
 
Figure A.95. 
1
H NMR spectrum of 17 in CDCl3, aryl region expansion. 
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Figure A.96. 
13
C{
1
H} NMR spectrum of 17 in CDCl3. 
 
 
 
 
 
Figure A.97. 
13
C{
1
H} NMR spectrum of 17 in CDCl3, aryl region expansion. 
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Figure A.98. 
31
P{
1
H} NMR spectrum of 17 in CDCl3. 
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Figure A.99. 
1
H NMR spectrum of 18 in CDCl3. 
 
 
 
Figure A.100. 
1
HNMR spectrum of 18 in CDCl3, alkyl region expansion. 
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Figure A.101. 
1
H NMR spectrum of 18 in CDCl3, aryl region expansion. 
 
 
 
 
 
Figure A.102. 
13
C{
1
H} NMR spectrum of 18 in CDCl3. 
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Figure A.103. 
13
C{
1
H} NMR spectrum of 18 in CDCl3, aryl region expansion.  
 
 
 
 
 
Figure A.104. 
31
P{
1
H} NMR spectrum of 18 in CDCl3. 
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APPENDIX B 
FT-IR SPECTRA 
 
 
Figure B.1. IR spectra of aqueous H2O2 in 35 wt% (top) and 17 wt% (bottom).  
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Figure B.2. IR spectrum of 1. 
 
 
 
 
 
Figure B.3. IR spectrum of 2. 
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Figure B. 4 IR spectra of 3 before (bottom) and after (top) deuteration.  
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Figure B.5. IR spectrum of 4. 
 
 
 
 
 
 
Figure B.6. IR spectrum of 5. 
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Figure B.7. IR spectrum of 6. 
 
 
 
 
 
 
Figure B.8. IR spectrum of 7. 
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Figure B.9. IR spectrum of 8. 
 
 
 
 
 
 
Figure B.10. IR spectrum of 9. 
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Figure B.11. IR spectrum of 10. 
 
 
 
 
 
 
Figure B.12. IR spectrum of 1,1-di(hydroperoxy)cyclohexane. 
 171 
 
 
Figure B.13. IR spectrum of 11. 
 
 
 
 
 
 
Figure B.14. IR spectrum of 1,1-di(hydroperoxy)heptane. 
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Figure B.15. IR spectrum of 12. 
 
 
 
 
 
 
Figure B.16. IR spectrum of 13. 
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Figure B.17. IR spectrum of 14. 
 
 
 
 
 
 
Figure B.18. IR spectrum of 15. 
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Figure B.19. IR spectrum of 16. 
 
 
 
 
 
 
Figure B.20. IR spectrum of 18. 
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APPENDIX C 
DECOMPOSITION DATA 
 
 
 
Figure C.1. Oxidizing power of 3 after being stored at the indicated conditions. 100% 
equals to 2 moles of active oxygen per mole of 3. 
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Figure C.2. Oxidizing power of 4 after being stored at the indicated conditions. 100% 
equals to 2 moles of active oxygen per mole of 4. 
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Figure C.3. Oxidizing power of 6 after being stored at the indicated conditions. 100% 
equals to 2 moles of active oxygen per mole of 6. 
 
  
 
 
 
Table C.1. Decomposition temperature of adducts 4-15.  
 
Adduct 
Decomposition 
T (ºC) 
Adduct 
Decomposition 
T (ºC) 
4 75 10 121 
5 70 11 138 
6 54 12 100 
7 108 13 120 
8 138 14 105 
9 152 15 110 
 
